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Abstract - Nasal carriage of methicillin-resistant coagulase-positive staphylococci among 
cats and dogs hospitalized in the Veterinary Teaching Hospital of the Faculty of 
Veterinary Medicine – Technical University of Lisbon, Portugal 
 
Methicillin-resistant coagulase-positive staphylococci (MRCPS) colonization in companion 
animals is an emerging and significant problem in public and animal health. During one year, 
nasal swabs were obtained from 40 cats and 146 dogs admitted to the Teaching Hospital of 
the Faculty of Veterinary Medicine - Technical University of Lisbon. MRCPS colonization 
was screened by plating enrichment cultures on a selective medium, Chrom MRSA ID. 
Bacterial species and mecA were confirmed by PCR. Clonality of the isolates was assessed by 
pulsed-field gel electrophoresis (PFGE). All isolates were subjected to spa and SCCmec 
typing. They were also tested by PCR for the lukF/lukS genes encoding Panton-Valentine 
leukocidin (PVL) in Staphylococcus aureus and Luk-I and Staphylococcus intermedius 
exfoliative toxin (SIET) in Staphylococcus pseudintermedius. Methicillin-resistant S. aureus 
(MRSA) was found in two cats (5 %) and one dog (0.6 %). Isolates were spa type t032, 
SCCmec IV and shared identical PFGE profiles. These were similar to the EMRSA-15 human 
clone. Strains were PVL-negative. Nine dogs carried methicillin-resistant S. pseudintermedius 
(MRSP) (6 %), whereas none of the cats was positive. The PFGE type A strain (n=1) showed 
identical characteristics as the American MRSP clone strains (CC68-MRSP-V), while PFGE 
cluster B grouped European MRSP isolates (CC71-MRSP-III) (n=8). All isolates were SIET-
negative. The 8 European MRSP isolates were positive for the lukF/lukS genes and the 
American MRSP isolate was negative for both genes. Strains were multidrug-resistant, which 
represents a major challenge for veterinarians in terms of antibiotic therapy. 
 






Resumo - Frequência de colonização por staphylococci coagulase-positivo meticilina-
resistente em cães e gatos internados no hospital escolar da Faculdade de Medicina 
Veterinária – Universidade Técnica de Lisboa, Portugal 
 
A colonização por staphylococci coagulase-positivo meticilina-resistente (MRCPS) é um 
problema emergente e de grande importância em termos de saúde animal e pública. Durante 
um ano, zaragatoas nasais de 146 cães e 40 de gatos foram obtidas de animais internados no 
Hospital Escolar da Faculdade de Medicina Veterinária - Universidade Técnica de Lisboa. A 
colonização por MRCPSfoi pesquisada por inoculação de culturas de enriquecimento num 
meio selectivo, Chrom MRSA ID. As espécies de MRCPS e a amplificação do gene mecA por 
feita por PCR. A clonalidade dos isolados foi confirmada por PFGE. Todos os isolados foram 
sujeitos a tipagem spa e SCCmec. Os isolados de S. aureus meticilina-resistente (MRSA) e de 
S. pseudintermedius meticilina-resistente (MRSP) foram testados por PCR para a presença 
dos genes lukF/lukS que codificam, respectivamente, a leucocidina Panton-Valentine (PVL) e 
a leucocidina-I (Luk-I). Os isolados de MRSP foram ainda testados para a presença da toxina 
exfoliativa do S. intermedius (SIET). Nesta amostra, 0,6 % (n=1) dos cães testados e 5 % 
(n=2) dos gatos apresentaram MRSA. Os isolados de MRSA eram spa tipo t032, SCCmec IV 
e partilhavam padrões idênticos de PFGE. As estirpes eram idênticas ao clone humano 
EMRSA-15. Os 3 isolados eram PVL negativos. Nove cães apresentaram MRSP (6 %), 
enquanto nenhum dos gatos foi positivo. PFGE tipo A mostrou características idênticas ao 
clone americano de MRSP (CC68-MRSP-V) e PFGE tipo B agrupou os isolados europeus de 
MRSP (CC71-MRSP-III) (n=8). Os isolados de MRSP PFGE tipo B eram Luk-I positivos 
mas SIET negativos. Todas as estirpes de MRSP eram multirresistentes a várias classes de 
antibióticos, o que representa um desafio para os médicos veterinários em termos de 
estratégias de antibioterapia. 
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In February 2008, I initiated a project with Professor Constança Pomba and Dr. Paula Tilley, 
both teachers at the Faculty of Veterinary Medicine – Technical University of Lisbon (FMV-
UTL). The objective of the study was to investigate the carriage of methicillin-resistant 
Staphylococcus aureus (MRSA) strains among horses with Chronic Obstructive Pulmonary 
Disease. My work consisted on inoculating the nasal swabs in an enrichment broth, collected 
by a colleague, Joana Simões, and posterior characterization of the isolated strains. This work 
was performed at the Laboratory of Antimicrobial and Biocide Resistance of the FMV-UTL, 
run by Professor Constança. No MRSA strains were isolated, but we found a high frequency 
of isolation of methicillin-resistant coagulase-negative staphylococci strains from horses 
affected by the disease. Dr. Paula presented an oral communication at the 3
rd
 AMVE 
Congress 2008 entitled “Estudo da Colonização no Cavalo por Staphylococcus Meticilina-
Resistentes” [Study of the colonization by methicillin-resistant Staphylococcus in horses] 
(Annex I).  
During the same year, I collaborated in the identification of Staphylococcus species in a 
CIISA (Interdisciplinary Centre of Research in Animal Health) project about Canine Atopy. 
An oral communication describing the first case of pyoderma caused by methicillin-resistant 
Staphylococcus simulans in a dog with atopic dermatitis was presented to the 17
th
 APMVEAC 
National Congress 2008 entitled “Primeiro caso de infecção cutânea por Staphylococcus 
simulans meticilina resistente num cão com dermatite atópica em Portugal” [First case of a 
cutaneous infection by a methicillin-resistant Staphylococcus simulans in a dog with atopic 
dermatitis in Portugal] (Annex II). I also participated in the Portuguese European Union 
baseline study for the detection of MRSA in breeding pigs and in the identification of MRSA 
in pigs with exudative epidermiditis. 
In April of 2008, we started a new project: Determination of the frequency of isolation of 
methicillin-resistant coagulase-positive staphylococci strains among cats and dogs 
hospitalized at the Teaching Hospital of the FMV-UTL, which became later my Master 
dissertation subject. The Teaching Hospital receives small animal patients for first consults in 
internal medicine, radiology and surgery. Also receives patients for first and second opinion 
consults on dermatology, neurology, cardiology, ophthalmology, endocrinology, orthopedics 
and animal behavior. The hospital has a vast casuistic and many animals are admitted to the 
internment for various medical reasons. Normally, I collected nasal swabs in the morning, 
which is usually the period of animal internment. During a one year period (from April 2008 
to April 2009) I swabbed 146 dogs and 40 cats admitted to the Teaching Hospital and 
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processed them at the Laboratory of of Antimicrobial and Biocide Resistance of the FMV-
UTL.  
In 2009, we presented an oral communication at the 18
th
 APMVEAC National Congress 2009 
under the title “Frequência de colonização por staphylococci coagulase-positivo em gatos 
internados no hospital escolar da FMV-UTL” [Frequency of colonization by methicillin-
resistant coagulase-positive staphylococci in cats hospitalized at the teaching hospital of 
FMV-UTL] (Annex III), three posters at the ASM-ESCMID Conference on Methicillin-
resistant Staphylococci in Animals: Veterinary and Public Health Implications, designated 
“Nasal carriage of methicillin-resistant coagulase-positive staphylococci among cats and dogs 
hospitalized in a Veterinary Teaching Hospital in Portugal” (Annex IV), “First description of 
an MRSA skin infection in a dog and attending veterinarian in Portugal” (Annex V) and 
“High-frequency of clindamycin associated resistance among MRSA CC398 from breeding 
swine herds in Portugal” (Annex VI) and one poster at the VI OMV Congress 2009, named 
“Frequência de colonização por staphylococci coagulase-positivo meticilina-resistente em 
cães internados no hospital escolar da FMV-UTL” [Frequency of colonization by methicillin-
resistant coagulase-positive staphylococci in dogs hospitalized at the teaching hospital of 
FMV-UTL] (Annex VII).  
During three months (from October 2009 to December 2009) I undertook the LLP/Erasmus 
Program and went to Copenhagen to work in the Microbiology Laboratory of the Faculty of 
Life Sciences, University of Copenhagen. I was working under the supervision of Professor 
Luca Guardabassi and Doctor Arshnee Moodley, on the molecular characterization of my 
MRSP isolates and collaborating in other small projects.  
In late 2009, we submitted a case report with the name “Treatment of a lower urinary tract 
infection in a cat caused by a multidrug-methicillin-resistant Staphylococcus 
pseudintermedius and Enterococcus faecalis” (Annex VIII) in collaboration with Doctor 
Arshnee Moodley, to the Journal of Feline Medicine, which was accepted early this year.  
In February of this year, Professor Constança challenged me to present a small clinical case 
and some results of the study in a Strategies of Antimicrobial Therapy in Veterinary Medicine 
class, which I accepted gladly.  
In April we submitted an article to the Veterinary Microbiology Journal, entitled “Nasal 
colonization of methicillin-resistant Staphylococcus aureus (EMRSA-15) and methicillin-
resistant Staphylococcus pseudintermedius (CC71 and CC68) clones among hospitalized cats 







Staphylococci are important pathogenic bacteria, long known to cause infection in mammals. 
There are different species, but the main classification of staphylococci is based on their 
ability to produce coagulase, an enzyme that causes blood clot formation (Blair, 1962). In 
early times, only coagulase-positive staphylococci were thought to have the ability to cause 
infection (Blair, 1962). Due to their ubiquitous nature and relatively low virulence, coagulase-
negative staphylococci were considered to be clinically insignificant contaminants when 
isolated from clinical specimens (Pfaller & Herwaldt, 1988). However, in recent years 
coagulase-negative staphylococci have become increasingly recognized as important agents of 
nosocomial infection, especially those related to indwelling devices (Pfaller & Herwaldt, 
1988). 
Coagulase-positive staphylococci can cause a variety of diseases, which vary in morbidity and 
mortality. Wound and cut infections, minor skin infections (pimples, impetigo, boils, 
cellulitis, folliculites, carbuncules, scalded skin syndrome and abscesses) and transient food 
poisoning have low mortality rates (Blair, 1962). On the other hand, pneumonia, toxic shock 
syndrome, meningitis, endocarditis, osteomyelitis, bacteremia and sepsis are life-threatening 
diseases caused by more virulent strains (Lowy, 1998). Staphylococci can produce a wide 
variety of toxins that can be divided in two categories: those which enable the colonization of 
the host and infection (e.g. coagulase, hyaluronidase, leukocidin) and those which damage the 
tissues or affect their normal functions (e.g. enterotoxins) (Blair, 1962).  
Inside the coagulase-positive staphylococci group, Staphylococcus aureus and Staphylococcus 
pseudintermedius are the two most important species in Veterinary Medicine, due to their 
ability to cause infection and their zoonotic potential (Weese & van Duijkeren, 2010). 
Methicillin resistance emerged in these two organisms, raising the concern for animal and 
public health (Weese & van Duijkeren, 2010).  
 
2.1  Methicillin-resistant Staphylococcus aureus 
 
In 1882, Ogston first described staphylococcal disease and its role in sepsis and abscess 
formation. More than 100 years later, S. aureus remains an adaptable and dangerous pathogen 
in humans (Lowy, 1998). Treatment of infections with S. aureus has become more difficult 
because of the emergence of multidrug-resistant strains (Lowy, 1998). 
The genome of S. aureus consists of a circular chromosome, with prophages, plasmids and 
transposons (Lowy, 1998). Genes encoding virulence and resistance to antibiotics are found 
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on the chromosome and in extrachromosomal elements (Lowy, 1998), which enables the 
possibility of gene transference between staphylococci strains, species or other gram-positive 
bacterial species (Schaberg & Zervos, 1986).  
S. aureus produces numerous toxins that are grouped on the basis of their mechanisms of 
action (Lowy, 1998). The synthesis of many of these proteins is dependent on the growth 
phase (Lowy, 1998). Nearly all strains secrete a group of enzymes and cytotoxins that cause 
pore formation and induce proinflammatory changes in mammalian cells (Lowy, 1998; 
Dinges, Orwin & Schlievert, 2000). Cytotoxins include four hemolysins (alpha, beta, gamma 
and delta), nucleases, proteases, lipases, hyaluronidase and coagulase (Dinges et al., 2000). 
These bacterial products may facilitate the spread of infection to other tissues, but their role in 
the pathogenesis of disease is not well defined (Lowy, 1998). Some strains produce one or 
more additional exoproteins, which include toxic shock syndrome toxin-1 (TSST-1), the 
staphylococcal enterotoxins, the exfoliative toxins and leukocidin (Dinges et al., 2000). 
Panton-Valentine leukocidin (PVL) is made as two non-associated secreted proteins, referred 
as to S and F components (S for slow- and F for fast-eluting proteins in an ion-exchange 
column) (Woodin, 1959; Woodin, 1960). PVL is leukotoxic (by pore induction) for rabbit and 
human polymorphonuclear cells and macrophages (Lina et al., 1999; Dinges et al., 2000). 
PVL appears to be a virulence factor associated with necrotic lesions of the skin (Prévost et 
al., 1995a) and subcutaneous tissues and necrotic pneumonia (Gillet et al., 2002), but its role 
in the progression of staphylococcal disease remains unclear (Lina et al., 1999; Dinges et al., 
2000). Many staphylococcal surface proteins have certain structural features in common 
(Lowy, 1998). These proteins have a ligand-binding domain at the N-terminal that is exposed 
on the surface of the bacterial cell enabling some of these proteins to function as adhesins 
(Foster & McDevitt, 1994). Protein A is a prototype of these proteins, which include also 
elastin-binding protein, collagen-binding protein, fibronectin-binding protein and clumping 
factor (see Figure 1) (Lowy, 1998). Protein A has antiphagocytic properties that are based on 
its ability to bind to the Fc portion of immunoglobulin G (IgG) (Uhlén et al., 1984). Protein A 
also exhibits an ability to bind to von Willebrand factor, a protein present at sites of damage 
of endothelium, and as a result, it can play a role in adherence and induction of endovascular 
diseases by S. aureus (Hartleib et al., 2000).  
 
Figure 1 – Structure of Staphylococcus aureus. Panel A shows the surface and secreted proteins, 
considered virulence factors. Altered penicillin-binding proteins and production of β-lactamases 
(shown inside the circles in panel B) are the two most important mechanisms of β-lactams resistance. 
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Many of the surface proteins have a structural organization similar to that of clumping factor and 
protein A, including repeated segments of amino acids (Panel C) (Adapted from Lowy, 1998). 
 
 
β-lactam antibiotics reach bacterial killing by binding to penicillin-binding proteins (PBP), 
proteins located in the cytoplasmic membrane that are involved in cell-wall assembly (see 
Figure 1) (Lowy, 1998; Gardam, 2000). By binding to these PBP, β-lactams consequently 
inhibit the crosslink of bacterial cell wall (Gardam, 2000). The initial mechanism of 
staphylococci resistance involved the production of β-lactamases, which hydrolyze the cyclic 
amide bond of the β-lactam ring (see Figure 1) (Gardam, 2000). Subsequently, after 
introduction of penicillinase-stable penicillins (like methicillin and oxacillin), a new 
mechanism of resistance developed and the S. aureus strains began producing a unique 
penicillin-binding protein, PBP2a or PBP2’, which has a much lower affinity for β-lactam 
antibiotics (including penicillins, cephalosporins, carbapenems) (Gardam, 2000; Weese & van 
Duijkeren, 2010). The gene encoding for PBP2a is mecA, which is part of a 21-to-60 kb 
mobile genetic element, termed staphylococcal chromosome cassette mec (SCCmec) (Lloyd, 
Boag and Loeffer, 2007). The origin of MRSA is matter of considerable controversy 
(Gardam, 2000). Kreiswirth et al. (1993), based on analysis of restriction fragment length 
polymorphisms (RFLP) generated by ClaI digestion of chromosomal Deoxyribonucleic acid 
(DNA) followed by hybridization with Tn554 and mecA probes, proposed that all MRSA 
descended from a single ancestral S. aureus strain that acquired the mecA gene on only one 
occasion. The same authors concluded that the horizontal transfer of the mecA gene between 
staphylococcal species was an extremely rare event (Kreiswirth et al., 1993). However there is 
Virulence Factors 
Resistance Mechanisms to β-lactams 
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a considerable genetic diversity between MRSA, meaning that mecA has been transferred 
between S. aureus lineages (Enright et al., 2002). Robinson and Enright (2003) summarized 
how the application of typing techniques, like multilocus sequence typing (MLST) and 
SCCmec typing, revealed evolutionary models of the emergence of MRSA: first it had been 
shown that MRSA arose on multiple occasions out of successful MSSA lineages; second 
methicillin resistance emerged in five phylogenetic distinct lineages (CC5, CC8, CC22, CC30 
and CC45); third only a small number of pandemic clones caused most MRSA disease. It is 
now accepted that modern MRSA represent independent acquisitions of SCCmec by different 
genetic lineages of S. aureus (Enright, 2003). The source of mecA gene is also subject of 
investigation (Gardam, 2000). The ccr and mec genes, which are the basis of SCCmec, are 
thought to have initially been introduced into coagulase-negative staphylococci from an 
unknown source and then into S. aureus (Enright et al., 2002). It is not known which 
staphylococcal species donated the SCCmec types found among MRSA, but some speculate 
that it could have come from Staphylococcus sciuri (Couto et al., 1996; Wu, Piscitelli, de 
Lencastre & Tomasz, 1996). Robinson and Enright (2003) indicated that at least 20 
acquisitions of SCCmec have occurred in S. aureus. Of these 20, 16 were acquisitions of 
SCCmec by a MSSA clone and 4 putative reacquisitions of SCCmec by an MRSA clone 
(Robinson & Enright, 2003). 
Isolation of methicillin-resistant S. aureus (MRSA) from animals was first described in 1972 
after its detection in milk from mastitic cows (Devriese, Vandamme & Fameree, 1972). This 
is not unexpected, since S. aureus is an important cause of mastitis in cattle and there is a 
widespread usage of intramammary antibiotics in that species (Leonard & Markey, 2008). 
MRSA was first isolated in dogs in the same year in Nigeria (Ojo, 1972). In Europe, MRSA 
was first described only in 1988, in a cat (Scott, Thomson, Malone-Lee & Ridgway, 1988). 
Since then MRSA has been increasingly reported as an emerging pathogen in veterinary 
medicine (Leonard & Markey, 2008). MRSA is capable of colonizing healthy animals and can 
affect all ages, breed and genders (Weese & van Duijkeren, 2010). However the actual rates 
of carriage of MRSA by dogs and cats are not known (Lloyd et al., 2007). Colonization rates 
in dogs range from 0 to 9 % (Baptiste et al., 2005; Loeffler et al., 2005; Lefebvre et al., 2006; 
Rich & Roberts, 2006; Vengust, Anderson, Rousseau, & Weese, 2006; Bagcigil, Moodley, 
Baptiste, Jensen & Guardabassi, 2007; Hanselman, Kruth & Weese, 2008; Boost, 
O’Donoghue & James, 2008; Griffeth, Morris, Abraham, Shofer & Rankin, 2008; Kottler, 
Middleton, Weese & Cohn, 2008), while in cats ranges from 0 to 4 % (Baptiste et al., 2005; 
Loeffler et al., 2005; Abraham, Morris, Griffeth, Shofer, & Rankin, 2007; Hanselman et al., 
2008; Kottler et al., 2008). However, there has been less investigation in cats then in dogs 
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(Weese and van Duijkeren, 2010). MRSA can develop opportunistic infections at various 
body sites, but the most often reported are wound infections, surgical site infections, 
pyoderma, otitis and urinary tract infections (Tomlin et al., 1999; Baptiste et al., 2005; 
Leonard et al., 2006; Morris, Mauldin, O’Shea, Shofer & Rankin, 2006a; Morris, Rook, 
Shofer & Rankin, 2006b; Vitale, Gross & Weese, 2006; Weese et al., 2006; Griffeth et al., 
2008). Risk factors for MRSA infection and colonization have been poorly investigated 
(Weese & van Duijkeren, 2010). Faires & Weese (2008) concluded that antimicrobial therapy, 
particularly with fluoroquinolones, appeared to be a risk factor for MRSA versus MSSA 
infection in dogs and cats. MRSA infections have also been associated with exposure to 
extensive wounds, prolonged hospitalization and immunosuppression (Duquette & Nuttall, 
2004). Other risk factors for acquisition of MRSA infections are: presence of a urinary 
catheter or a joint infection (Faires & Weese, 2008). Animals in contact with human hospitals 
and contact with children are in higher risk for MRSA colonization (Lefebvre, Reid-Smith, 
Waltner-Toews & Weese, 2009).  
Epidemiological studies have revealed the occurrence of indistinguishable clones in animals 
and in humans: e.g. CMRSA-5, EMRSA-15 and EMRSA-16 are major human epidemic 
clones that have been isolated from dogs and cats (Baptiste et al., 2005; Loeffler et al., 2005; 
O’Mahony et al., 2005; Hanselman et al., 2008; Pomba, Hasman, Cavaco, Couto & 
Aarestrup, 2009). These MRSA strains found in small animals tend to be those that 
predominate in people in the region (Weese & van Duijkeren, 2010). Loeffler et al. (2005) 
isolated EMRSA-15 from dogs in United Kingdom (UK), which is one of the two EMRSA 
strains (EMRSA-15 and EMRSA-16) currently prevalent in UK human hospitals. Weese et al. 
(2006) recovered Canadian epidemic MRSA-2 from household pets in Canada, which is the 
predominant community-associated MRSA human clone in Canada. This strongly suggests 
that the principal origin for MRSA colonization and infection in companion animals is 
through contact with humans infected with or carrying MRSA (Lloyd et al., 2007). 
Companion animals can then serve as reservoirs and act as a source of re-infection or re-
colonization (Leonard & Markey, 2008).  
The prevalence of MRSA in European countries varies, with Portugal having one of the 
highest (45 %) just behind Malta and Romania (see Figure 2) (European Antimicrobial 




Figure 2 – European map showing the Staphylococcus aureus proportion of invasive isolates resistant 
to oxacillin (MRSA) in 2007 (EARSS, 2007). 
 
 
Portuguese human hospitals have been analyzed since the early 1990s (Aires-de-Sousa, 
Conceição, Simas and de Lencastre, 2005; Aires-de-Sousa, Correia, de Lencastre & 
Multilaboratory Project Collaborators, 2008). Aires-de-Sousa et al. (2005) reported that at 
least three epidemiological important events were recorded in Portugal: (i) in 1992 and 1993, 
the Portuguese clone (ST239-MRSA-III) was replaced by the Iberian clone (ST247-MRSA-
IA); (ii) in 1994 and 1995, the emergence of the Brazilian clone (ST239-MRSA-III/IIIA) and 
its rapid dissemination; and (iii) recently (2001) the Brazilian clone (ST239-MRSA-III/IIIA) 
was replaced by the EMRSA-15 clone (ST22-MRSA-IV). EMRSA-15 clone is one of the two 
major clones (together with EMRSA-16) in the UK (Johnson et al., 2001). EMRSA-15 is 
replacing previous established clones in various regions of the world, including Europe 
(Aires-de-Sousa et al., 2008). The three dominant MRSA clones in Portuguese hospitals 
(Iberian-ST247, Brazilian-ST239 and EMRSA-15-ST22), or their ancestral genotypes, were 
not detected or scarcely found among an MSSA collection (Aires-de-Sousa et al., 2005). 
These facts suggest the three major clones have not originated from the introduction of 
SCCmec into main MSSA backgrounds present in the Portuguese nosocomial or community 
background but were probably imported from out of the country (Aires-de-Sousa et al., 2005). 
EMRSA-15 has been described in the community in healthy young adults in the absence of 
risk factors (Mollaghan, Lucey, Coffey & Cotter, 2010), in outpatients (Amorim et al., 2009; 
Marchese, Gualco, Maioli & Debbia, 2009), healthcare workers (Amorim et al., 2009) and 
veterinary surgeons (Pomba et al., 2009). 
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There have been some studies considering that veterinarians and veterinary personnel are at 
high risk of nasal MRSA colonization (Loeffler et al., 2005; O’Mahony et al., 2005; 
Hanselman et al., 2006; Moodley et al., 2006; McLean & Ness, 2008). However none of the 
studies proved that these colonization rates derived from acquisition of MRSA from animals 
(Weese and van Duijkeren, 2010). Still these higher rates provide support of possible 
occupational origin (Weese and van Duijkeren, 2010). MRSA infections in owners with 
involvement of their companion animals are recognized too (van Duijkeren et al., 2004; van 
Duijkeren, Wolfhagen, Heck & Wannet, 2005; Leonard & Markey, 2008; Morgan, 2008). A 
recently study has proved that veterinary staff and owners of infected pets are risk groups for 
MRSA carriage (Loeffler et al., 2010). 
There are no treatment protocols for MRSA infections in animals (Lloyd et al., 2007). When 
deciding for the best treatment protocol, veterinarians should take in account the antibiotic 
sensitivity pattern of the MRSA isolated, the severity of the infection and other co-morbid 
conditions or the underlying disease (Lloyd et al., 2007). The antimicrobial therapy should be 
chosen considering the culture and antimicrobial susceptibility testing results and MRSA 
clones prevalent in the geographical area, which can help set an empirical therapy while 
waiting for the microbiological results (Lloyd et al., 2007). In Portugal, only one MRSA 
strain was isolated in a dog and it was co-resistant to fluoroquinolones (Pomba et al., 2009). 
Potentiated sulphonamides, tetracyclines and lincosamides are usually the antimicrobials of 
choice for systemic therapy (Loeffler, 2008). If the infection is in the superficial layers of the 
skin, the treatment should also include topical antibacterial therapy such as ointments, creams 
or shampoos (Loeffler, 2008).  
There are no guidelines for when decolonization should be performed in animals, however 
treatment of carrier animals should be accomplished if there is a possibility of re-infection or 
if the carriers have not been infected but present a risk to other animals or to humans in 
contact with them (Lloyd et al., 2007). Decolonization can be achieved with topical therapy 
with fusidic acid, mupirocin, chlorhexidine and benzoyl peroxide (Lloyd et al., 2007; 
Loeffler, 2008). Decolonization should only be performed after carriage has been confirmed, 
through swabbing of the nose, mouth or perineum, and when infection is being resolved 
(Loeffler, 2008). 
 
2.2  Methicillin-resistant Staphylococcus pseudintermedius 
 
In 1976, a new species within the genus Staphylococcus, Staphylococcus intermedius, was 
characterized as coagulase positive staphylococci isolated from pigeons, dogs, minks and 
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horses (Hajék, 1976). However, strains isolated from different animal species showed 
sometimes diverse characteristics and confusion about the classification of S. intermedius was 
a problem during some decades (Weese & van Duijkeren, 2010). In 2005, Devriese and co-
workers described a new species, Staphylococcus pseudintermedius which had high 
similarities with Staphylococcus delphini, S. intermedius and Staphylococcus schleiferi 
(Devriese et al., 2005). On this basis S. pseudintermedius was classified within the S. 
intermedius group (SIG). In order to determine the prevalence of each species within the SIG, 
Sasaki and colleagues (2007b) reclassified 117 S. intermedius originated from cats, dogs, 
humans, pigeons, horses, minks and dolphins. They concluded that phenotypically identified 
S. intermedius strains were reclassified into at least four clusters (S. intermedius, S. 
pseudintermedius, S. delphini groups A and B). Moreover, all dog strains were identified as 
being S. pseudintermedius strains (Sasaki et al., 2007b). Bannoehr et al. (2007) came to the 
same conclusion and for this reason all strains isolated from dogs are now being classified as 
S. pseudintermedius, unless it’s proven by genomic assays that the strains belong to another 
species within the genus (Devriese, Hermans, Baele & Haesebrouck, 2009). It should be taken 
in consideration that previous studies reporting S. intermedius from dogs might be in fact 
reporting S. pseudintermedius (Weese & van Duijkeren, 2010).  
Differentiation between the members of the SIG by phenotypical tests is very difficult. S. 
intermedius is easily differentiated from SIG strains by a combination of phenotypical 
characteristics such as positive arginine dihydrolase and acid production from ß-gentiobiose 
test and D-mannitol (Sasaki et al., 2007b). In contrast, there is no difference in the 
biochemical profile between S. pseudintermedius and S. delphini (Sasaki et al., 2007b). 
Commercial identification systems for the fast and correct identification of S. 
pseudintermedius are not available to date, because the phenotypic properties of S. 
intermedius, S. delphini and S. pseudintermedius resemble one another (Sasaki et al., 2007a). 
In many cases S. pseudintermedius isolates will be erroneously identified as S. intermedius or 
S. aureus (Devriese et al., 2005; Van Hoovels, Vankeerberghen, Boel, Van Vaerenbergh & 
De Beenhouwer, 2006; Schwarz, Kadlek & Strommenger, 2008). 
S. pseudintermedius integrates the normal flora of the nares, mouth, anus, groin and forehead 
of healthy dogs and cats (Abraham et al., 2007; Griffeth et al., 2008). As well as S. aureus in 
humans, S. pseudintermedius is an opportunistic pathogen that can cause infections of the skin 
and ears (Moodley, Stegger, Zakour, Fitzgerald & Guardabassi, 2009), post-operative wound 
infections (Moodley et al., 2009), urinary tract infections (Wettstein, Descloux, Rossano & 
Perreten, 2008) and respiratory tract infections (Schwarz et al., 2008). Furthermore S. 
pseudintermedius, and not S. intermedius, is the primary pathogen isolated from canine 
11 
 
pyoderma (Bannoehr et al., 2007). However, little is known about the pathogenesis of S. 
pseudintermedius (Fitzgerald, 2009). Still, like other staphylococci, S. pseudintermedius has 
the ability to produce a number of virulence factors, some closely related to those produced 
by S. aureus. S. pseudintermedius produces enzymes such as coagulase, proteases and 
thermonuclease and toxins, including haemolysins, exfoliative toxins and enterotoxins 
(Fitzgerald, 2009). Staphylococcus intermedius exfoliative toxin (SIET) is a well known 
exfoliative toxin that seems to be the causative agent of canine pyoderma (Lautz et al., 2006). 
Terauchi and colleagues proved that dogs injected with purified SIET developed clinical signs 
like erythema, exfoliation and crusting which are equal to the signs of canine pyoderma and 
human staphylococcal scalded skin syndrome (Terauchi et al., 2003). S. pseudintermedius 
also produces a leukotoxin known as Luk-I, which is very similar to PVL from S. aureus 
(Futagawa-Saito et al., 2004). Luk-I is encoded as a luk-I operon with co-transcribed genes, 
lukS and lukF, encoding LukS and LukF, respectively (Prévost, Bouakham, Piemont & 
Monteil, 1995b). Luk-I shows a strong leukotoxicity on various polymorphonuclear cells, 
including activity on human leukocytes, but only a minor hemolytic activity on rabbit 
erythrocytes (Prévost et al., 1995b). In 2009, Geoghegan and colleagues determined that S. 
pseudintermedius expresses surface proteins that resemble those from S. aureus (Geoghegan, 
Smith, Speziale & Foster., 2009). They discovered that S. pseudintermedius has the capacity 
to bind to fibrinogen, fibronectin and cytokeratin 10, which could explain how S. 
pseudintermedius adheres to canine corneocytes in colonization and in infection (Geoghegan 
et al., 2009). Moodley and co-workers, in 2009 reported that S. pseudintermedius produces an 
immunoglobulin-binding protein similar to S. aureus, the so called protein A. Protein A is 
encoded by the staphylococcal protein A gene (spa). The spa gene of S. pseudintermedius has 
68 % nucleotide and 55 % predicted amino acid identity with the homologous gene in S. 
aureus (Moodley et al., 2009) and is thought to be a potential virulence factor (Moodley et al., 
2009). Like most staphylococci, S. pseudintermedius has the capacity to form biofilms 
(Haenni, Bréchard & Madec, 2009).  
Like in MRSA, methicillin resistance in S. pseudintermedius is mediated by the mecA gene 
(Loeffler et al, 2007; Moodley et al., 2009). Methicillin-resistant S. pseudintermedius (MRSP) 
was already isolated from dogs, cats and humans, which turns it to a zoonotic pathogen (Van 
Hoovels et al., 2006; Bannoehr et al., 2007; Hanselman et al., 2008; Sasaki et al., 2007b; 
Schwarz et al., 2008; Wettstein et al 2008; Chuang, Yang, Hsueh & Lee, 2010). MRSP 
infections were mostly associated with veterinary clinic epidemic outbreaks (Weese & van 
Duijkeren, 2010), although colonization of healthy animals and people working with animals 
has been described (Sasaki et al., 2007a; Hanselman et al., 2008; Boost, So & Perreten, 2009). 
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In Europe, a single common genotype (ST71) was found to be prevalent in the northern and 
central part of the continent (Bannoehr et al., 2007; Boost et al., 2009; Moodley et al., 2009; 
Perreten et al., 2010; Ruscher et al., 2010). ST71 is also prevalent in Hong Kong (Moodley et 
al., 2009). These MRSP isolates were generally distinct from MRSP isolated in North 
America (Bannoehr et al., 2007; Moodley et al., 2009; Perreten et al., 2010). Black et al. 
(2009) and Moodley et al. (2009) analyzed MRSP strains isolated in the United States of 
America by MLST and determined that the strains belonged to ST68. However, this clone 
was isolated in Portugal in a cat in 2009 (Pomba, Couto & Moodley, 2010). A single spa type 
(t06) was detected among the American isolates belonging to ST68 while multiple spa types 
(t02, t03, t04, t05 and t09) were identified within the European clone ST71 (Moodley et al., 
2009). It was hypothesized that broad geographic dissemination of sucessful MRSP genetic 
lineages had happened and that the spread had occurred in an amazing short period of time 
(Bannoehr et al., 2007; Ruscher et al., 2010). Alternatively, Ruscher et al. (2010) postulated 
that ST71 could represent a very successful S. pseudintermedius-lineage that could co-
evolved with the canine host and disseminated widely in European countries in the past, even 
though there is a lack of ST 71 MSSP. The same authors identified new spa types associated 
with the ST71 (t05, t06, t15 and t23). These ST71-associated spa types differ only slightly by 
the number of a certain repeat (on to five r03-repeats) at a central position on the spa gene. 
Therefore, variations in ST 71 related spa types were possibly a result of repeated loss of r03-
repeats by deletion events (Ruscher et al., 2010). This is the first report of t06 associated with 
European ST71 isolates but further investigation of the functional aspects of the presumptive 
spa gene is necessary (Ruscher et al., 2010). ST71 and ST68 contain distinct SCCmec 
elements, type III and type V, respectively (Sasaki et al., 2007a; Moodley et al., 2009; 
Ruscher et al., 2009; Ruscher et al., 2010). Descloux and colleagues (2008) reported a new 
SCCmec type, SCCmec type II-III, associated with Swiss ST71 isolates. However, according 
to Kondo criteria (Kondo et al., 2007) this SCCmec element would have been classified as 
type III (class A mec complex and ccrAB3 recombinase) (Moodley et al., 2009). This 
SCCmec consists of a combination of SCCmec II from Staphylococcus epidermidis and of 
SCCmec III from S. aureus and lacks the cadmium resistance operon (Descloux, Rossano & 
Perreten, 2008). Recently a new SCCmec element was described, SCCmec VII-241 (class A 
mec complex and ccrA3/B5), which is not related to SCCmec VII from S. aureus (Black et al., 
2009; Perreten et al., 2010).  
In addition to resistance to β-lactams, MRSP isolates are displaying resistance to many classes 
of antimicrobial agents (Perreten et al., 2010), sometimes more than 4 classes, which turns 
them into multidrug-resistant strains. In late 1990s and early 2000s resistance to several 
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antimicrobial classes was rare and S. pseudintermedius had never presented as a therapeutic 
problem in pets in Europe (Lloyd, Lamport & Feeney, 1996; Guardabassi, Loeber & 
Jacobson, 2004). Loeffler et al. (2005) reported the first MRSP in Europe. These MRSP 
strains had been isolated from dogs with skin and ear infections and were co-resistant to 
enrofloxacin, clindamycin, erythromycin, tetracycline and trimethoprim-sulfamethoxazole, 
but susceptible to gentamicin, rifampicin, fusidic acid and mupirocin. After, resistance to 
gentamicin, chloramphenicol, tobramycin, levofloxacin and ciprofloxacin has been reported 
among MRSP strains (Schwarz et al., 2008; Wettstein et al., 2008; Ruscher et al., 2009; 
Perreten et al., 2010; Ruscher et al., 2010).  
As for MRSA, veterinarians and owners of dogs infected with MRSP are at higher risk of 
carrying an MRSP strain (Weese & van Duijkeren, 2010). In one study, owners of dogs with 
deep pyoderma were shown to be more often cultured positive for S. pseudintermedius than 
individuals without daily contact with dogs and they often carried the same S. 
pseudintermedius strain as their dogs (Guardabassi et al., 2004). Sasaki and colleagues 
(2007a) identified an MRSP among the veterinary staff sampled. Van Duijkeren et al. (2008) 
identified MRSP in environment samples and veterinary personnel in a clinic which were 
epidemiologically related. People working at veterinary clinics and hospitals should be aware 
of the risk of nosocomial transmission of MRSP and take precautions to avoid it (Weese & 
van Duijkeren, 2010). 
The treatment of infections with MRSP is a new challenge in veterinary medicine because of 
the very limited therapeutic options (Wettstein et al. 2008). The multidrug-resistance patterns 
results in a potential pressure for veterinarians to use unauthorised antimicrobials available in 
human medicine which requires careful evaluation of extra-label drug use in veterinary 
medicine (Weese and van Duijkeren, 2010).  
 
2.3  Typing of methicillin-resistant staphylococci strains  
 
The epidemiology of infectious diseases relies on typing methods as tools for the 
characterization and discrimination of isolates based on either their genotypic or phenotypic 
characteristics, which may be used to establish clonal relationships between strains and to 
trace the geographic dissemination of bacterial clones (Faria, Carrico, Oliveira, Ramirez & de 
Lencastre, 2008).  
Phenotypic typing methods comprise colonial characteristics, biochemical reactions, 
antibiotic susceptibility pattern, susceptibility to various phages and toxin production 
(Leonard & Markey, 2008).  
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Even though antibiotic susceptibility pattern is still frequently used as a tool to characterize 
bacterial isolates, nowadays, the classification of isolates is mostly based on molecular 
methods, which usually provide better discriminatory power than phenotypic methods (Faria 
et al., 2008). For molecular typing there are various methods proposed, but the most important 
and globally used are pulsed-field gel electrophoresis (PFGE), multilocus sequence typing 
(MLST), spa and SCCmec typing. 
 
2.3.1  Pulsed-Field Gel Electrophoresis (PFGE) 
 
PFGE separates DNA under conditions of alternating polarity allowing for the resolution of 
DNA fragments nearly 20-times larger than those separated by traditional agarose gel 
electrophoresis (Leonard & Markey, 2008). PFGE is used in combination with restriction 
enzymes to give a DNA fingerprint of the bacterial genome (Tenover et al., 1995). The DNA 
restriction patterns of the isolates are then compared with one another to determine their 
relatedness (Tenover et al., 1995). The main advantage of this technique is that it provides 
great discrimination among strains and is useful in the investigation of outbreaks, by allowing 
differentiation of unrelated strains and another advantage is its high resolution (Prévost, 
Jaulhac & Piemont, 1992; Struelens, Deplano, Godard, Maes & Serruys, 1992; Schlichting et 
al., 1993; Struelens, Bax, Deplano, Quint & van Belkum, 1993; Tenover et al., 1994; Nada et 
al., 1996; Na’was et al., 1998; Schmitz et al., 1998; Olive & Bean, 1999; Oliveira et al., 2001; 
Montesinos, Salido, Delgado, Cuervo & Sierra, 2002; Strommenger et al., 2006; Faria et al., 
2008; Leonardo & Markey, 2008). Disadvantages relate principally with difficulties with 
inter-laboratory comparison of results and consequently reliable comparison of strains 
between regions and internationally are not always possible (Leonard & Markey, 2008). Other 
disadvantages are the consuming time that it takes to get the results and the expensive cost of 
the method (Montesinos et al., 2002).  
In 2003, Murchan et al., in a multicenter study, described a consensus PFGE protocol for 
typing of strains of MRSA which resulted in higher intercenter reproductibility, local 
acceptability and the establishment of a web-based database of harmonized MRSA SmaI 
restriction patterns (Murchan et al., 2003). This protocol has been adapted, with minor 
modification, for use in MRSP strains using the same restriction enzyme, SmaI (Perreten et 






2.3.2  Multilocus Sequence Typing (MLST) 
 
MLST was first developed for the identification of the hypervirulent lineages of Neisseria 
meningitidis (Maiden et al., 1998) and for assigning Streptococcus pneumoniae strains to 
major hypervirulent clones (Enright & Spratt, 1998; Enright, Fenoll, Griffiths & Spratt, 
1999). MLST is a highly discriminatory method of characterizing bacterial isolates on the 
basis of the sequences of ~ 450 bp of internal fragments of seven housekeeping genes 
(Maiden et al., 1998). For each gene fragment, the different sequences are assigned as distinct 
alleles and each isolate is defined by the alleles at each of the seven housekeeping loci (the 
sequence type [ST]) (Enright, Day, Davies, Peacock & Spratt, 2000). MLST sequences of the 
seven gene fragments of some bacteria can be readily compared between laboratories via the 
internet (http://www.mlst.net). MLST reveals slowly accumulating changes in conserved 
genes that reflect long-term evolutionary changes and can identify global spread of the 
relatively small number of successful clones (Enright et al., 2002). MLST has become popular 
due to development in large-scale sequencing methodology, ease of data transfer and 
excellent comparability of results (Aires-de-Sousa et al., 2006), however MLST is not 
appropriate for routine infection control due to high cost, labor intensity and lack of broad 
access to high-throughput DNA sequencing (Strommenger et al., 2006). 
In order to overcome the difficulty of comparing PFGE results and the genetic relatedness of 
the clones of EMRSA described by different laboratories, Enright and colleagues (2000) 
developed a multilocus sequence typing for MRSA. Out of the fourteen housekeeping gene 
fragments sequenced by Enright et al. (2000), the seven housekeeping gene fragments that 
provided the greatest number of alleles were chosen for use in the MLST scheme and 
included: carbamate kinase gene (arcC), shikimate dehydrogenase gene (aroE), glycerol 
kinase (glpF), guanylate kinase (gmk), phosphate acetyltransferase (pta), triosephosphate 
isomerase (tpi) and acetyl coenzyme A acetyltransferase (yqiL). The MLST scheme for S. 
aureus was developed in 2000 and the details of several isolates are available at the S. aureus 
MLST website http://saureus.mlst.net (Enright et al., 2000).  
With the aim of investigating the population genetic structure of the SIG, Bannoehr and 
colleagues (2007) developed a multilocus sequencing approach that included five gene loci 
with a range of predicted nucleotide diversities to facilitate inter- and intraspecies 
differentiation. Five loci, the 16S rRNA (16S ribosomal RNA), cpn60 (chaperonin 60), tuf 
(elongation factor Tu), pta (phosphate acetyltransferase) and agrD (autoinducing peptide-
AIP) genes were selected for DNA sequence analysis based on previous single-locus 
approaches to differentiating staphylococcal species (16S rRNA, cpn60 and tuf) and on 
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inclusion of some genes (pta, cpn60 and tuf) into multilocus sequence typing schemes for 
differentiating strains of several different bacteria species (Bannoehr et al., 2007). The allelic 
variation of agrD was examined to further investigate both inter- and intraspecies 
discrimination (Bannoehr et al., 2007). There is no available S. pseudintermedius MLST 
website, therefore MLST sequences must be compared with allele sequences present in the 
NCBI nucleotide database  in order to determine the allele number (Perreten et al., 2010). 
Sequence type numbers are assigned using the key table for MLST typing of SIG isolates 
(Bannoehr et al., 2007). The current S. pseudintermedius MLST scheme needs optimization, 
as most of MLST schemes have seven or more loci and none includes 16S rRNA (Perreten et 
a., 2010). 
 
2.3.3  spa Typing 
 
In 1996, Frenay and colleagues developed a single-locus sequence typing method for S. 
aureus using the sequence of polymorphic X or short sequence repeat (SSR) region of the spa 
gene as an alternative technique for the typing of S. aureus (Frenay et al., 1996). The 
polymorphic X region consists of a variable number of 21 bp to 27 bp repeats and is located 
upstream of the region encoding the C-terminal cell wall attachment sequence (Guss et al., 
1984; Schneewind, Model & Fischetti, 1992; Uhlen et al, 1984). The diversity of the SSR 
region seems to arise from deletion and duplication of the repetitive units and also by point 
mutation (Brigido et al., 1991). The existence of well-conserved regions flanking the X region 
coding sequence in spa gene allows the use of primers for PCR amplification and direct 
sequence typing (Shopsin et al., 1999). Moreover, the determination of spa types was 
simplified when appropriate software synchronized with an accompanying public website was 
developed (http://www.SpaServer.ridom.de) (Harmsen et al., 2003). A potential problem with 
spa typing is that it involves sequencing of only one small region of the chromosome, which 
is subject to recombinant between unrelated clones (Cookson et al., 2007). This could result 
in isolates exhibiting the same spa type when they are shown to be unrelated by other 
methods (Cookson et al., 2007). 
In 2009, Moodley and colleagues described the use of spa sequencing as a technique for S. 
pseudintermedius typing. The sequencing of the spa gene of S. pseudintermedius revealed that 
it was shorter then the spa gene of S. aureus, partly due to the lack of IgG-binding domain 
region B (Moodley et al., 2009). In S. pseudintermedius the polymorphic X region consists of 
variable numbers (between 6 and 10) of 30 bp tandem repeats (Moodley et al., 2009). All 
MRSP isolates tested yelded spa PCR products (100 %), but the typeability rate among 
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methicillin-susceptible isolates was lower (58 %) (Moodley et al., 2009). The spa products of 
non-typeable isolates could not be sequenced due to the presence of multiple bands, which 
was found to be related to the presence of two adjacent spa genes (Perreten et al., 2010). This 
second spa gene has three IgG-binding domains and a partial deletion of the X region, but the 
biological significance of this gene duplication is unclear (Perreten et al., 2010). Like in S. 
aureus, the variable region X in S. pseudintermedius consisted of duplications or deletions of 
whole repeats or point mutations within repeats (Moodley et al., 2009).  
 
2.3.4  SCCmec Typing 
 
SCCmec is a mobile genetic element characterized by the presence of terminal inverted and 
direct repeats, a set of site-specific recombinase (ccr) genes and the mecA gene complex (Ito, 
Katayama & Hiramatsu, 1999; Katayama, Ito & Hiramatsu, 2000). Each SCCmec element 
integrates at the same site (attBSCC) at the 3’ end of an open reading frame (ORF) of unknown 
function, designated orfX (Ito et al., 1999). There are five classes of mec gene complex (A to 
E), which vary in their genetic structure (Katayama, Ito & Hiramatsu, 2001; Lim, Chong, 
O’Brien & Grubb, 2003). SCCmec consists of three regions: a mec complex carrying an intact 
copy of mecA, when present, complete or truncated mec regulatory genes mecI and mecR, a 
ccr complex carrying cassette chromosome recombinase (ccr) genes and a serious of variable 
“junkyard” or “J” regions (Ito, Okuma, Ma, Yuzawa, Hiramatsu, 2003; Lim et al., 2003). 
According to the International Working Group on the Classification of Staphylococcal 
Cassette Chromosome Elements (IWG-SCC) there are eight currently established SCCmec 
types (International Working Group on the Classification of Staphylococcal Cassette 
Chromosome Elements [IWG-SCC], 2009).  
 
3  Objectives of the study 
 
The primary objective of the study was to investigate the frequency of MRSA and MRSP 
colonization in cats and dogs hospitalized at the Teaching Hospital of the Faculty of 
Veterinary Medicine, Technical University of Lisbon. The second objective was to 
characterize the isolates by molecular methods and relate them with previous described 
epidemic clones as well as their possible pathogenic potential (frequency of the PVL toxin in 
S. aureus and Luk-I and SIET in S. pseudintermedius). 
For this purposes we defined our protocol considering previous studies. Nasal swabbing was 
chosen as the method for screening the small animals for colonization, since the nostrils are 
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the predominant site of colonization for both MRSA and MRSP (Weese & van Duijkeren, 
2010). The inoculation broths were those proposed elsewhere for detection of MRSA in 
animals (Vengust et al., 2006). Chrom MRSA ID, the selective agar for screening of 
methicillin-resistance, was chosen because is sensitive and specific for differentiation between 
MSSA and MRSA in vitro, as showed by the study of Diederen et al. (2006).  
MRS strains were typed by PFGE, spa typing and SCCmec typing. MLST was not used due 
to economical reasons. Since spa types can unambiguously be assigned to, a limited number 
of clonal lineages known to be prevalent (Strommenger et al., 2006), the MRS were assigned 
a Clonal Complex (CC) based on the spa type.  
 
4 Materials and Methods 
 
4.1 Sampling and collection of data on antimicrobial treatment 
 
During a one year study (from April 2008 to April 2009), nasal swabs were obtained from 
cats and dogs immediately or at the most two hours after admission to the Teaching Hospital 
of the FMV-UTL. Forty cotton swabs from cats and 146 from dogs were rolled on the nasal 
mucosae of both nostrils and were immediately processed at the laboratory. A brief 
questionnaire about each animal was completed, that included gender, age, breed, presenting 
complaint, antimicrobial use in the last month and in the last year, hospitalization and 
previous surgery (Annex X). 
 
4.2 Bacterial isolation and characterization 
 
4.2.1 Strains isolation 
 
The nasal swabs were inoculated in 3 ml of an enrichment broth consisting of 10 g/l mannitol, 
65 g/l NaCl, 2,5 g/l yeast extract and 10 g/l tryptone for 24 h at 37º C (Vengust et al., 2006). 
After overnight incubation, 10 μl of bacterial suspension were inoculated in Columbia 5% 
blood sheep agar plates, again for 24 h at 37º C (bioMérieux, Marcy l’Etoile, France). 
Colonies were identified as coagulase-positive staphylococci based on colony morphology, 
ability to cause hemolysis, gram straining, positive catalase test, positive tube coagulase test 




 typing system (BD BBL, New Jersey, 








4.2.2 DNA Extraction 
 
DNA extraction protocol was adapted from the European Union Reference Laboratory of 
Antimicrobial Resistance (EURL) protocol available on the Internet (http://www.crl-ar.eu). In 
brief, 1 ml of PBS was transferred to a 1.5-ml eppendorf tube and, using a disposable 
inoculation loop (white; 1μl), a loop full of bacteria was picked from a plate and transferred to 
the eppendorf tube. After, the eppendorf was centrifuged at 14,000 x g for 5 min. The 
supernatant was discarded and the pellet re-suspended in 100 μl TE 10:1. The suspension was 
boiled for 5-10 minutes and transferred directly to ice. Finally the lysed DNA was diluted 10 
times in TE 10:1 and was stored at -20º C. 
 
4.2.3 Methicillin resistance confirmation 
 
MRSA and MRSP carriage was screened by plating enrichment cultures on a selective 
medium, Chrom MRSA ID (bioMérieux) and suspected colonies (see Figure 3) were 
confirmed by PCR to have the mecA gene.  
 
Figure 3 – Aspect of MRSA colonies on Chrom MRSA ID medium (bioMérieux). 
 
 
Amplification of the mecA, 16S rRNA and nuc of S. aureus genes was carried out in a 





Figure 4 – M-PCR profile of MRSA and S.aureus. M, DNA ladder; 1, 2 and 5, Test strains S. aureus; 
3, 16S control coagulase-negative Staphylococcus; 4, Mastermix negative control; 6, MRSA. 
 
 
 M-PCR was performed in a final volume of 50 μl containing 5 μl of the DNA template, 2 μl 
of each of the following primers Mec-1 (10 μM), Mec-2 (10 μM), Nuc-1 (10 μM), Nuc-2 (10 
μM), 16S-1 (10 μM), 16S-2 (10 μM) (see Table 1), 0.5 μl of NZYTech Taq (NZYTech, 
Lisbon, Portugal), 5 μl of 10x PCR buffer without MgCl2, 6 μl of MgCl2 (25 mM), 0.5 
deoxyribonucleotide triphosphates (dNTPs) (25 mM) and 21 μl of MiliQ water. Thermal 
cycling reactions consisted of an initial denaturation (5 minutes at 94˚ C) followed by 30 
cycles of denaturation (30 s at 94˚ C), annealing (30 s at 55˚ C) and elongation (60 s at 72˚ C), 
with a single final elongation (10 min at 72˚ C). 
 
4.2.4 Species confirmation 
 
Presumptive S. aureus and S. pseudintermedius isolates were confirmed by PCR amplification 
of the specific nuc gene. The nuc gene of S. aureus was amplified through the M-PCR 
described above (http://www.crl-ar.eu). The nuc gene of S. pseudintermedius was adapted 
from the protocol described by Sasaki et al. (2010).  PCR was performed in a final volume of 
50 μl containing 2 μl of the DNA template, 2 μl of each of the following primers Pse F(10 
μM) and Pse R (10 μM) (see Table 1), 0.5 μl of Dream Taq (Fermentas), 5 μl of 10x PCR 
buffer, 0.5 μl dNTPs (25 mM) and 40 μl of MiliQ water. Thermal cycling reactions consisted 
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of an initial denaturation (2 min at 95˚ C) followed by 30 cycles of denaturation (30 s at 95˚ 
C), annealing (35 s at 56˚ C) and elongation (60 s at 72˚ C), with a single final elongation (2 
min at 72˚ C). 
Discrimination between S. pseudintermedius and S. intermedius was further investigated by 
restriction fragment length polymorphism (RFLP) analysis of the pta gene (Bannoehr, Franco, 
Iurescia, Battisti & Fitzgerald, 2009). PCR amplification of a 320 bp fragment of the pta gene 
was carried out in a 50 μl volume with 2 μl of each oligonucleotide primers (pta_f1 and 
pta_r1) (see Table 1), 0.8 μl dNTP’s, 0.5 μl Taq DNA Polymerase (Fermentas) and 5 μl DNA 
template in a 10x reaction buffer. Thermocycling conditions included a 94º C incubation for 1 
minutes, followed by 30 cycles of 94º C for 1 min, 53º C for 1 min and 72º C for 1 min, with 
a final incubation of 72º C for 7 min. Twenty five microliter samples of the PCR mixtures 
were incubated with 5 U of MboI (Fermentas) and 5 μl of 5x digestion buffer for 2 hours. The 
digestion products were resolved in 2 % (w/v) agarose by electrophoresis.  
 
4.2.5 PVL, Luk-I and SIET detection 
 
MRSA isolates were tested by PCR for the presence of lukF/lukS genes encoding PVL using 
the primers described by Lina et al. (1999). Briefly, PCR was performed in a final volume of 
50 μl containing 2 μl of the DNA template, 0.5 μl of each of the following primers luk-PV-1 
(10 μM) and luk-PV-2 (10 μM) (see Table 1), 0.5 μl of Taq DNA Polymerase (Fermentas), 5 
μl of 10x PCR buffer, 0.5 dNTPs (25 mM) and 41 μl of MiliQ water. Thermal cycling 
reactions consisted of an initial denaturation (5 minutes at 94˚ C) followed by 30 cycles of 
denaturation (30 s at 94˚ C), annealing (30 s at 55˚ C) and elongation (60 s at 72˚ C), with a 
single final elongation (10 min at 72˚ C). 
MRSP isolates were tested by two PCR for the presence of lukF and lukS genes encoding 
Luk-I using the primers described by Futagawa-Saito et al. (2004). Briefly, both PCR were 
performed in a final volume of 25 μl containing 2 μl of the DNA template, 2 μl of each of the 
following primers lukF pseud F (10 μM) and lukF pseud R (10 μM) or lukS pseud F (10 μM) 
and lukS pseudo R (10 μM) (see Table 1), 0.5 μl of Dream Taq Polymerase (Fermentas), 5 μl 
of 10x PCR buffer, 0.5 dNTPs and 12 μl of MiliQ water. Thermal cycling reactions consisted 
of an initial denaturation (2 minutes at 94˚ C) followed by 35 cycles of denaturation (60 s at 
94˚ C), annealing (60 s at 55˚ C) and elongation (60 s at 72˚ C), with a single final elongation 
(10 min at 72˚ C). 
SIET gene was amplified by PCR based on the protocol described by Lautz et al. (2006). This 
protocol consists of a first preparation of a PCR master mix consisting of 2 μl of the DNA 
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template, 2 μl of each of the following primers siet 1 toxin (10 μM) and siet 2 toxin (10 μM) 
(see Table 1), 0.5 μl of Dream Taq Polymerase (Fermentas), 2 μl of 10x PCR buffer, 0.8 
dNTPs and 16.7 μl of MiliQ water in a final volume of 25 μl. The thermocycling conditions 
were the following: an initial denaturation (3 minutes at 94˚ C) followed by 35 cycles of 
denaturation (30 s at 94˚ C), annealing (30 s at 56˚ C) and elongation (60 s at 72˚ C), with a 
single final elongation (10 min at 72˚ C). 
 
4.3 spa Typing  
 
For MRSA, spa typing was performed as recommended by the EURL (http://www.crl-ar.eu). 
PCR was accomplished in a final volume of 50 μl containing 2 μl of the DNA template, 0.5 μl 
of each of the following primers SPA 1095F new (10 μM) and SPA extended_f (10 μM) (see 
Table 1), 0.5 μl of Dream Taq Polymerase (Fermentas), 5 μl of 10x PCR buffer, 0.5 dNTPs 
(25 mM) and 41 μl of MiliQ water. Thermal cycling reactions consisted of an initial 
denaturation (5 minutes at 94˚ C) followed by 35 cycles of denaturation (45 s at 94˚ C), 
annealing (45 s at 62˚ C) and elongation (90 s at 72˚ C), with a single final elongation (10 min 
at 72˚ C). For DNA sequencing, 100 μl of the PCR products were purified using the 
JETQUICK PCR Product Purification Spin Kit (GENOMED, GmbH Löhne, Germany). DNA 
sequencing was performed by STAB VIDA (Lisbon, Portugal). The spa types were assigned 
through the Ridom web server (http://www.ridom.de/spaserver/). 
For MRSP, spa typing was performed according to Moodley et al. (2009). PCR was 
performed in a final volume of 25 μl containing 1.5 μl of the DNA template, 2.5 μl of each of 
the following primers SIspaF2 (5 μM) and SIspaR3 (5 μM) (see Table 1), 12.5 μl of Dream 
Taq Green Master Mix (Fermentas) and 6 μl of MiliQ water. Thermal cycling reactions 
consisted of an initial denaturation (10 minutes at 95˚ C) followed by 30 cycles of 
denaturation (30 s at 95˚ C), annealing (30 s at 58˚ C) and elongation (60 s at 72˚ C), with a 
single final elongation (10 min at 72˚ C). For DNA sequencing, 10 μl of the PCR products 
were purified adding 1 μl of Exonuclease enzyme (20 U/ μl) and 4 μl of Alkaline Phosphatase 
(1 U/ μl) and incubating at 37˚ C for 15 min and then at 80˚ C for 15 min. DNA sequencing 
was performed by Macrogen Inc. (Seoul, South Korea) using BigDye (Applied Biosystems). 





Table 1 – List of primers used in the study. 












Pse F 5’-TRGGCAGTAGGATTCGTTAA-3’ 
926 bp 
Pse R 5’-CTTTTGTGCTYCMTTTTGG-3’ 
pta_f1 5’-AAAGACAAACTTTCAGGTAA-3’ 
320 bp 




lukF pseud F 5’-CCTGTCTATGCCGCTAATCAA-3’ 
572 bp 
lukF pseud R 5’-AGGTCATGGAAGCTATCTCGA-3’ 
lukS pseud F 5’-TGTAAGCAGCAGAAAATGGGG-3’ 
503 bp 
lukS pseud R 5’- GCCCGATAGGACTTCTTACAA-3’ 
siet1 tox 5’-ATGGAAAATTTAGCGGCATCTGG-3’ 
359 bp 
siet2 tox 5’-CCATTACTTTTCGCTTGTTGTGC-3’ 
SPA 1095F new 5'-AGACGATCCWTCAGTGAGC-3' 
Variable 





4.4 SCCmec Typing  
 
Staphylococcal cassette chromosome mec types were determined using the multiplex PCR 1 
and multiplex PCR 2 accordingly to Kondo and collaborators (2007) and accordingly to the 
IWG-SCC (2009). PCRs were performed in a final volume of 25 μl containing 0.5 μl of the 
DNA template, 5 μl of a 10x primer mix, 12.5 μl of Dream Taq Green Master Mix 
(Fermentas) and 7 μl of MiliQ water. Thermal cycling reactions consisted of an initial 
denaturation (5 minutes at 94˚ C) followed by 35 cycles of denaturation (2 min at 94˚ C), 
annealing (60 s at 57˚ C) and elongation (3 min at 72˚ C), with a single final elongation (8 
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min at 72˚ C). The molecular weight of each PCR amplicon was determined and assigned to a 
particular allele type in each strain. The combination of the type ccr and mec complex was 
used to assign SCCmec types.  
 
4.5 Antimicrobial Susceptibility Testing 
 
Antimicrobial susceptibility testing was performed by the disk diffusion method. The results 
were registered after incubation at 37˚ C for 18h, measuring the diameter of the zone of 
inhibition, if present, for each antibiotic used. Inhibition zone diameters were interpreted 
according to the Clinical Laboratories Standards Institute clinical breakpoints for animals 
(CLSI, 2008) and, when breakpoints were unavailable for bacteria of animal origin, according 
to the human CLSI breakpoints (CLSI, 2009). For fusidic acid and mupirocin, inhibition zone 
diameters were interpreted using breakpoints proposed by Toma and Barriault (1995) and 
Fuchs et al. (1999), respectively. Susceptibility test breakpoints for oxacillin of S. 
pseudintermedius were those described by Bemis et al. (2009). For MRSA and MRSP, the 
following antimicrobial discs (Oxoid, Hampshire, United Kingdom) were used: amikacin (30 
μg), cephalothin (30 μg), chloramphenicol (30 μg), ciprofloxacin (5 μg), clindamycin (2 μg), 
enrofloxacin (5 μg), erythromycin (15 μg), fusidic acid (10 μg) gentamicin (10 μg), 
kanamycin (30 μg), levofloxacin (5 μg), linezolid (30 μg), marbofloxacin (5 μg), 
moxifloxacin (5 μg), mupirocin (5 μg), nitrofurantoin (300 μg), norfloxacin (10 μg), ofloxacin 
(5 μg), oxacillin (1 μg), penicillin G (10 units), quinupristin/dalfopristin (15 μg), rifampicin (5 
μg), tetracycline (30 μg), trimethoprim (5 μg), and vancomycin (30 μg). MRSA was also 
tested for cefoxitin (30 μg) susceptibility, since cefoxitin has been recently used to replace 




PFGE was performed as described by Murchan et al. (2003) with minor modifications. 
Briefly, bacterial cultures were grown overnight in brain heart infusion broth (BD Difco, New 
Jersey, USA) and were incorporated into 2 % (w/v) agarose discs, instead of plugs. After four 
hours lysis with lysostaphin (5 mg/ml), lysozyme (100 mg/ml) and RNase (32,5 mg/ml) at 37º 
C, the discs were incubated with proteinase K (20 mg/ml) overnight at 56º C and one disc was 
digested with SmaI (20 U/ml) overnight at room temperature. PFGE was performed by 
clamped homogeneous electric field (CHEF) electrophoresis with a CHEF-DR III System 
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(Bio-Rad Laboratories, San Diego, USA) in a 1,1 % (w/v) agarose gel with a pulsing switch 
time of 2-5 s at 5,6 V/cm for 24 h for MRSP and pulsing switch time of 5-15 s at 6 V/cm for 
10 h followed by pulsing switch time of 15-60 s at 6 V/cm for 13 h for MRSA. EMRSA-15 
and American MRSP clones, previously isolated in Portugal (Pomba et al., 2009; Pomba et 
al., 2010), were used as reference strains and included in the gel. The gels were inspected 





Twelve methicillin-resistant staphylococci were isolated from the nose of ten dogs and two 
cats out of a total of 186 animals screened. One hundred forty six animals were dogs (78 %) 
and forty were cats (22 %) (see Figure 5).  
 
Figure 5 – Percentage of the species of the animals sampled. 
 
 
Males were the predominant gender sampled (49 %), followed by females (31 %), females 
castrated (14 %) and males castrated (6 %) (see Figure 6).  
 





One hundred seventeen animals (63 %) had received antimicrobial treatment within the month 
prior to sampling and forty nine animals (26 %) had received antimicrobial treatment within 
the year before sampling. Many classes of antimicrobials were prescribed, but the classes 
more often selected were β-lactams, metronidazole and fluoroquinolones (see Figure 7 and 
Figure 8).  
 
Figure 7 – Number of antimicrobials prescribed to the animals in the study within the month prior to 
swab collection. Take in account that some animals received more than one antimicrobial. 
 
 
Figure 8 – Number of antimicrobials prescribed to the animals in the study within the year before the 





The three animals carrying a MRSA isolate had received antimicrobial treatment the month 
before the nasal swab collection and one animal in the year before too (see Table 2). Six 
animals colonized with MRSP had received antimicrobial treatment one month previous to 
sampling and four one year before (see Table 2). 
 
Table 2 – Species, gender, age and antimicrobial consumption of the companion animals colonized 
with MRSA and MRSP. 







FMV 1 Canine Female Unknown Surgery Spiramycin/Metronidazole Spiramycin/Metronidazole 






















Acid and Metronidazole 
Unknown 



















FMV 9 Canine Male 8 years Surgery 
Enrofloxacin, Cefoxitin and 
Metronidazole 
Unknown 

















MRSP strains were identified in 9 dogs, with a frequency of 6 % (see Figure 9). Two pattern 
of resistance were seen: FMV 1 strain demonstrated resistance to oxacillin, gentamicin, 
kanamycin, ciprofloxacin, enrofloxacin, levofloxacin, marbofloxacin, moxifloxacin, 
norfloxacin, ofloxacin, erythromycin and trimethoprim (see Table 3); the other 8 strains, FMV 
2 to 9, demonstrated resistance to oxacillin, gentamicin, kanamycin, ciprofloxacin, 
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enrofloxacin, levofloxacin, marbofloxacin, moxifloxacin, norfloxacin, ofloxacin, clindamycin, 
erythromycin, tetracycline and trimethoprim (see Table 3). One of the isolates, FMV 1, was 
spa type t06 belonging to the CC68 and the other eight, FMV 2 to 9, were t02 and 
consequently were CC71. According to Kondo and colleagues criteria (2007), isolate FMV 1 
harbored a SCCmec type V (class C mec complex and ccrC recombinase) and the other 8 
isolates, FMV 2 to 9, harbored a variant of the SCCmec type III (class A mec complex and 
ccrAB3 recombinase) (see Table 4). All isolates were typeable with SmaI-PFGE, resulting in 
the detection of two PFGE clusters (A and B) (see Figure10). The type B was subdivided into 
3 subtypes (B1 to B3) (see Table 4). The PFGE type A strain showed identical characteristics 
as the American MRSP clone (ST68-MRSP-V), while PFGE cluster B grouped European 
MRSP isolates (CC71-MRSP-III) (see Table 4). PFGE typing results were in agreement with 
those obtained by spa and SCCmec typing. All isolates were SIET-negative. The 8 European 
MRSP isolates were positive for the luF/lukS genes and the American MRSP isolate was 
negative for both genes. 
 






















MRSA was found in two cats (5 %) and one dog (0.6%) (see Figure 9). The same pattern of 
resistance was seen for the three isolates (FMV 10, 11 and 12): oxacillin, ciprofloxacin, 
enrofloxacin, levofloxacin, marbofloxacin, moxifloxacin, norfloxacin and ofloxacin (see 
Table 3). Tandem repeat sequence analysis of the spa gene concluded that all isolates were 
t032 and thus belonged to the CC22. All isolates harbored SCCmec type IV (class B mec 
complex and ccrAB2 recombinase) (see Table 4). A close relation to the European 
disseminated clone EMRSA-15 (ST22-MRSA-IV) was present: PFGE analysis revealed the 
same PFGE type (C) (see Figure 11) among the isolates, including with the previously 
described EMRSA-15 strain (ST22-MRSA-IV) causing skin infection in a dog and the 
attending veterinarian in Portugal (Pomba et al., 2009). All isolates were PVL negative. 
29 
 
Figure 10 – PFGE profiles (A, B) and subtypes (B1–B3) observed among MRSP isolated from dogs. 
 
 
Figure 11 – PFGE profile (C) observed among MRSA isolates. 
 
A 
C C C 
B1 B1 B1 B1 B2 B1 B3 B1 B1 
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Table 3 – Susceptibility testing by disk diffusion of 27 antimicrobial agents of methicillin-




Clinical Breakpoints Criteria 






































































 30 μg ≥ 17 15-16 - ≤ 14 S S S S S S S S S S S S 
Gentamicin
a
 10 μg ≥ 15 13-14 - ≤ 12 R R R R R R R R R S S S 
Kanamycin
a
 30 μg ≥ 18 14-17 - ≤ 13 R R R R R R R R R S S S 
Rifampicin
a
 5 μg ≥ 20 17-19 - ≤ 16 S S S S S S S S S S S S 
Cephalothin
a
 30 μg ≥ 18 15-17 - ≤ 14 S R R R R R R R R S S S 
Cefoxitin
b
 30 μg ≥ 20 - - ≤ 19 S R R R S R R S R S S S 
Oxacillin
a,c
 1 μg ≥ 13 11-12 - ≤ 10 NA NA NA NA NA NA NA NA NA R R R 
Oxacillin
d,e
 1 μg ≥ 20 - - < 20 R R R R R R R R R NA NA NA 
Penicillin G
a
 10 U ≥ 29 - - ≤ 28 R R R R R R R R R R R R 
Ciprofloxacin
b
 5 μg ≥ 21 16-20 - ≤ 15 R R R R R R R R R R R R 
Enrofloxacin
a
 5 μg ≥ 23 - 17-22 ≤ 16 R R R R R R R R R R R R 
Levofloxacin
b
 5 μg ≥ 19 16-18 - ≤ 15 R R R R R R R R R R R R 
Marbofloxacin
a
 5 μg ≥ 20 15-19 - ≤ 14 R R R R R R R R R R R R 
Moxifloxacin
b
 5 μg ≥ 24 21-23 - ≤ 20 R R R R R R R R R R R R 
Norfloxacin
b
 10 μg ≥ 17 13-16 - ≤ 12 R R R R R R R R R R R R 
Ofloxacin
b
 5 μg ≥ 18 15-17 - ≤ 14 R R R R R R R R R R R R 
Vancomycin
a
 30 μg ≥ 15 - - - S S S S S S S S S S S S 
Clindamycin
a
 2 μg ≥ 21 15-20 - ≤ 14 I R R R R R R R R S S S 
Erythromycin
a
 15 μg ≥ 23 14-22 - ≤ 13 R R R R R R R R R S S S 
Linezolid
b
 30 μg ≥ 21 - - - S S S S S S S S S S S S 
Chloramphenicol
a





15 μg ≥ 19 16-18 - ≤ 15 S S S S S S S S S S S S 
Tetracycline
a
 30 μg ≥ 19 15-18 - ≤ 14 S R R R R R R R R S S S 
Trimethoprim
b
 5 μg ≥ 16 11-15 - ≤ 10 R R R R R R R R R S S S 
Nitrofurantoin
b
 300 μg ≥ 17 15-16 - ≤ 14 S S S S S S S S S S S S 
Fusidic Acid
f
 10 μg ≥ 21 20 - ≤ 19 S S S S S S S S S S S S 
Mupirocin
g
 5 μg ≥ 14 - - ≤ 13 S S S S S S S S S S S S 
Abbreviations: NA, not applicable; R, resistant; S, susceptible. 
Inhibition zone diameters were interpreted according to:
 (a)




Bemis et al., 2009; 
(d) 
Criteria only for MRSA; 
(e) 
Criteria only for MRSP; 
(f)
 Toma and Barriault 1995; 
(g)
 Fuchs et al., 1990 
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Table 4 – Origin, genotypic characteristics and antimicrobial resistant patterns of mecA-positive S. aureus and S. pseudintermedius strains isolated. 





Tandem Repeat Sequence  CC 
PFGE 
Subtype 






















 V t06 r01r02 r03 r03 r06 r05 68 A 





























III t02 r01r02 r03 r03 r03 r06 r05 71 B1 





























III t02 r01r02 r03 r03 r03 r06 r05 71 B2 





























III t02 r01r02 r03 r03 r03 r06 r05 71 B1 





























III t02 r01r02 r03 r03 r03 r06 r05 71 B1 





























III t02 r01r02 r03 r03 r03 r06 r05 71 B3 





























III t02 r01r02 r03 r03 r03 r06 r05 71 B1 





























III t02 r01r02 r03 r03 r03 r06 r05 71 B1 














































 IV t032 



















 IV t032 



















 IV t032 
r26 r23 r23 r13 r23 r31 r29 r17 r31 r29 r17 r25 r17 r25 r16 
r28 
22 C 
Abbreviations: Cn, gentamicin; K, kanamycin; Cip, ciprofloxacin; Enr, enrofloxacin; Lev, levofloxacin; Mar, marbofloxacin; Mxf, moxifloxacin; Nor, norfloxacin; Ofx, ofloxacin; 






This is the first study to report the prevalence of MRSA and MRSP colonization in small 
animals in Portugal. MRSP was the predominant coagulase positive methicillin-resistant 
Staphylococcus in dogs, while MRSA was the main in cats. This is in accordance with 
previous reports (Hanselman et al., 2008). The origin of MRSA and MRSA in these small 
animals is unclear, but the genetic variety of isolates suggests that the two organisms may be 
spread in the dog and cat population, as has been proposed before (Sasaki et al., 2007; 
Hanselman et al., 2008). There were several limitations to this study. All data was collected at 
a single geographic location with no follow-up on colonized animals and therefore we cannot 
conclude the source or duration of colonization. Although there was a high prevalence of 
methicillin-resistant coagulase-positive staphylococci, the small sample size was prohibitive 
for assessment of potential risk factors for colonization.  
MRSI colonization was not identified which is in agreement with previous reports (Sasaki et 
al., 2007a; Hanselman et al., 2008). 
The incidence of MRSA in Human Portuguese Hospitals remains one of the highest in 
Europe, with dominance of the EMRSA-15 clone (ST22-MRSA-IV) (Aires-de-Sousa et al., 
2008). Thus, it is not surprising that the MRSA colonization strains isolated from our 
companion animals belong to this epidemic clone. Furthermore, MRSA ST22-SCCmec IV 
had been previously isolated from a skin infection in a dog and attending veterinarian in 
Portugal (Pomba et al., 2009). All isolates showed the same resistance profile as the epidemic 
EMRSA-15 (resistance to methicillin and ciprofloxacin). The origin of EMRSA-15 isolates in 
small animals remains unknown but several authors suggest that MRSA isolated from 
companion animals have a human source (Loeffler et al., 2005). As in our study, Loeffler and 
colleagues (2005) demonstrated the occurrence of EMRSA-15 in dogs in the United 
Kingdom, and pointed the epidemiological impact since it proves that this nosocomial 
pathogen is not restricted to hospitals and can be carried and disseminated by healthy humans 
and animals in the community. Little information is available to date on the risk of 
antimicrobial usage with regard to MRSA colonization in small animals (Catry et al., 2010). 
According to previous case reports, many animals infected or colonized with MRSA have 
been treated with antimicrobials prior to the diagnosis (Catry et al., 2010). Interestingly, our 3 
animals colonized with MRSA received antimicrobial treatment with amoxicillin-clavulanic 
acid one month prior to the nasal swab collection. Nevertheless, our sample is too small to 
prove antimicrobial administration was a risk factor and 63 % of non-colonized animals were 
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also exposed to antimicrobial administration, including amoxicillin-clavulanic acid, without 
development of MRSA colonization. 
In 2009, the first MRSP infection was identified in Portugal. The isolate was the co-source 
(together with Enterococcus faecalis) of a lower urinary tract infection in a cat and after 
molecular characterization was found to be associated with the American MRSP clone (ST68-
MRSP-V) (Pomba et al., 2010). To that date, this clone had been exclusively reported in the 
United States of America and Canada. The isolation of a second strain belonging to this clonal 
complex raises the question if it is already spreading through the European continent, too. 
More studies should be conducted to identify the real prevalence of this clone in Portugal and 
other European countries. 
The European MRSP clone (ST71-MRSP-III) has been implicated as responsible for 
infections in companion animals in Germany, Sweden and Switzerland (Wettstein et al., 
2008; Moodley et al., 2009) and more recently was isolated also from clinical samples 
throughout Europe (Perreten et al., 2010; Ruscher et al., 2010). Interestingly, European MRSP 
isolates show a multidrug-resistant pattern (resistance to more than 4 antimicrobial classes), 
with resistance to some aminoglycosides, quinolones, lincosamides, macrolides, tetracyclines, 
and folate pathway inhibitors (trimethoprim) (Loeffler et al., 2007; Wettstein et al., 2008; 
Ruscher et al., 2009; Perreten et al., 2010; Ruscher et al., 2010) and therefore they should be 
referred as multidrug-resistant S. pseudintermedius (MDRSP). The isolates in our study show 
exactly the same multidrug-resistant pattern. Surprisingly, our isolates show resistance not 
only to second and third generation quinolones, but also to a fourth generation 
fluoroquinolone, moxifloxacin, which has enhanced activity against gram-positive cocci 
(Ince, Zhang, & Hooper, 2003). This is an interesting fact since moxifloxacin is not licensed 
for veterinary use and prescription in Human Medicine is licensed only for the treatment of 
respiratory and skin infections. Intorre et al. (2007) found moxifloxacin-bordeline-
intermediate-resistant S. intermedius strains according to CLSI breakpoints and in 2009 
resistance to moxifloxacin was described in 45 clinical strains out of 46 MRSP strains 
(Ruscher et al., 2009). Intorre and co-workers (2007) found that resistance to the older 
fluoroquinolones was correlated with a double mutation in the quinolone-resistance-
determining regions (QRDR) within the genes gyrA (subunit of DNA gyrase) and grlA 
(subunit of topoisomerase IV) and speculated that an additional alteration in grlA was 
necessary for fourth generation fluoroquinolone’s resistance (Intorre et al., 2007). However 
the true mechanism of moxifloxacin-resistance in S. pseudintermedius remains unknown and 
further studies are required. This development of resistance to moxifloxacin and the 
observation of a multidrug-resistant pattern along European and American MRSP strains can 
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indicate that these strains have a high capacity of mutation or can easily acquire mobile 
elements, like transposons or plasmids, encoding resistance genes. 
Wettstein and colleagues (2008) also found resistance to chloramphenicol in their European 
MRSP strains, but our isolates do not demonstrate chloramphenicol resistance. This 
multidrug-resistance pattern represents a major challenge for veterinarians in terms of 
antibiotic therapy. Most of the drugs to which these bacteria remain susceptible are used off-
label in small animal practice (like amikacin, chloramphenicol and nitrofurantoin), others are 
used for human decolonization (fusidic acid and mupirocin) and others are last-resort drugs in 
human medicine (linezolid, quinupristin/dalfopristin, rifampicin and vancomycin). Moreover, 
linezolid, quinupristin/dalfopristin and vancomycin are considered antimicrobial limited for 
therapy of multidrug-resistant S. aureus infections by the joint Report of the FAO/WHO/OIE 
Expert Meeting (FAO/OIE/WHO, 2008). Thus, this represents a serious ethical dilemma, 
even when applying the “cascade principle”. Since there are no guidelines for treatment of 
infections with these MDRSP, it is up to every veterinarian to decide which antimicrobial to 
use. Most infections with MDRSP are skin and wound infections, otitis externa, respiratory 
infections and urinary tract infections (UTIs). Biocides, like chlorhexidine, triclosan, Tris-
EDTA and benzoyl peroxide, have been recommended for topical use in superficial skin 
infections and otitis externa. This approach is very successful and does not seem to select for 
antimicrobial resistance (Guardabassi, Ghibaudo & Damborg, 2009). However, care should 
be taken in order to also avoid development of resistance to biocides. Treatment of respiratory 
infections and UTIs with these MDRSP will be far more complicated to solve and precautions 
should be taken when choosing the antimicrobial therapy.  
The presence of Luk-I and SIET in MRSP CC71 has been previously described by Ruscher 
and colleagues in 2010. Our strains were SIET-negative but Luk-I-positive. Luk-I shows a 
strong toxicity on various polymorphonuclear cells, including human leukocytes, but only a 
slight hemolytic activity on rabbit erythrocytes (Futagawa-Saito et al., 2004). Because 
phagocytosis by polymorphonuclear cells is an important defense mechanism of the host, 
Luk-I may play a primary role in bacterial evasion to the host defense mechanisms, enhancing 
the opportunity of the cocci to colonize and set up an infection. Nevertheless the exact role by 
which Luk-I enables staphylococci colonization and infection is not completely understood 
and so its true meaning may be underestimated.  
The different colonization rates between dogs and cats of the two staphylococci species can 
indicate that the relative risk of MRSA and MRSP colonization might vary between the two 
host species, with MRSP being more frequent among dogs and MRSA among cats. The high 
rate of colonization of MRSP by dogs is likely to be due to host specificity, given that S. 
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pseudintermedius is the pathogen more frequently isolated from dogs (Sasaki et al., 2010). 
However, the same is not true for cats and the higher rate of MRSA colonization is not fully 
understood. Weese and van Duijkeren in 2010 referred that MRSA colonization might be 
transient in dogs and cats perhaps because S. aureus is not naturally a predominant 
commensal in these species. With S. pseudintermedius being the most prevailing commensal 
at least in dogs the duration of colonization is probably longer. Yet further studies on the 
duration of colonization are needed to evaluate this.  
Routine decolonization therapy is not recommended in human or animals that have mucosae 
colonized with MRSA (Catry et al., 2010). Nevertheless decolonization with antimicrobial 
therapy may be measured in individual MRSA colonized animals as an option to control 
transmission of MRSA between animals or from animals to humans (Catry et al., 2010). 
Animal confinement may also be considered. Still no antimicrobial drugs for veterinary use 
have been effectively studied and approved for local or systemic application intended to 
resolve MRSA carrier status. For MRSP decolonization there are no recommendations for 




In conclusion, even though the frequency of MRSA colonization was low, carriage of MRSA 
by companion animals in the community is a serious public health problem and adequate 
measures are necessary to prevent MRSA from becoming endemic in the animal population. 
The frequency of isolation of MRSP in our study was high (6 %), considering that MRSP was 
first described in Europe in 2006 and in Portugal in 2009. This carriage rate suggests that 
these bacteria are quickly spreading through the canine population through all Europe, 
including Portugal. How this dissemination has occurred is not completely understood 
(Perreten et al., 2010; Ruscher et al., 2010), however colonization of healthy animals can be 
an important way of transferring the pathogen from animal to animal.  
Although isolation of MRSP is infrequent in humans, transmission of strains between animals 
and humans has occurred in the past (Weese & van Duijkeren, 2010; Chuang et al., 2010). 
More important, the MDRSP strains can serve as reservoirs of antimicrobial resistance genes 
that can, possibly, be transferred to other bacterial species like S. aureus, since the location of 
many of these resistance genes is on mobile elements. Subsequent clonal spread of such a new 
MRSA clone might be a threat for human health in the future. The same may be applied for 
virulent toxins encoding genes among MRSP CC71 strains, which can play an important role 
in the dissemination of this epidemic clone. Recommendations for treatment of MDRSP 
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infections and decolonization are urgently needed and new treatments without the use of 
antimicrobials are required. 
More importantly, monitoring of MRSA and MRSP in companion animals should be 
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O Staphylococcus aureus é reconhecido como agente patogénico tanto em medicina humana 
como em medicina veterinária, podendo provocar desde infecções cutâneas ligeiras a 
situações de bacteriémia com risco de vida para o indivíduo. Surgiu pela primeira vez como 
agente patogénico com relevância para o ser humano na década de 70, nomeadamente em 
infecções hospitalares. Nos anos 90 já constituía uma infecção nosocomial séria a nível 
mundial, tendo nos últimos 10 anos vindo a ser relatado com importância crescente nos 
animais. As estirpes de MRSA (“methicillin-resistant Staphylococcus aureus”) são resistentes 
a todos os β-lactâmicos actualmente em uso em medicina veterinária, sendo a resistência 
mediada pelo gene mecA. Este gene codifica uma proteína que se liga à penicilina, PBP2a, a 
qual é expressa na parede celular bacteriana e tem baixa afinidade para antibióticos β-
lactâmicos. A prevalência de MRSA no homem varia muito com a área geográfica, sendo da 
ordem dos 60 % em algumas regiões dos Estados Unidos da América, 40 % no Sul da Europa 
e abaixo de 1 % no Norte da Europa (Leonard & Markey, 2008). Há evidência de que pode 
ocorrer transferência de estirpes de MRSA dos animais para o homem e vice-versa. Dados 
epidemiológicos obtidos por classificação fenotípica e molecular mostram que os isolados de 
cães e gatos não diferem dos do ser humano mas os isolados de cavalos e de pessoal que lida 
com eles são diferentes, estando ainda mal estudados. No cavalo as infecções por MRSA 
ocorrem preferencialmente em feridas cutâneas e em situações pós-operatórias, à semelhança 
do que ocorre no cão (Leonard & Markey, 2008). Encontram-se descritas infecções como 
artrite séptica, infecção no local de introdução do cateter endovenoso, pneumonia, infecção da 
ferida cirúrgica, mastite, rinite ou abcessos cutâneos. A principal via de transmissão parecem 
ser as mãos dos médicos veterinários. Também têm sido descritas infecções por estafilococos 
coagulase-negativo resistentes à meticilina (“methicillin-resistant coagulase negative 
staphylococci”- MRCoNS) (Trostle et al., 2001).  
Nesta perspectiva procedemos ao estudo da possível colonização nasal de 10 equídeos por 
MRSA. Recolheu-se uma zaragatoa nasal de cada cavalo. As zaragatoas foram inoculadas em 
meio de enriquecimento de Manitol selectivo para estafilococos e incubadas 37º C 18 h. Em 
seguida inocularam-se 10 μl em meio de Manitol com cefoxitina (3,5 mg/l) e aztreonam (75 
mg/l). Após incubação, 10 μl de suspensão bacteriana foram semeados em meio Chrom ID 
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MRSA (bioMérieux). Não foi detectado nenhum portador de MRSA. No entanto, 5 cavalos 
apresentaram outras espécies de estafilococos resistentes à meticilina: Staphylococcus sciuri 
(n=2), Staphylococcus lentus (n=1), Staphylococcus vitulus e S. sciuri (n=1), Staphylococcus 
spp. (n=1). Assim, no caso dos equinos este meio selectivo parece ser pouco específico não 
seleccionando exclusivamente MRSA, como acontece nos seres humanos para o qual foi 
desenvolvido (Diederen et al., 2006). Estas espécies de MRCoNS fazem parte da flora normal 
dos equinos (Vengust et al., 2006) e podem potencialmente causar infecção.  
A infecção por MRSA e MRCoNS é extremamente relevante em termos de saúde pública. Os 
animais podem ser fonte de infecção estafilocócica do ser humano, podendo funcionar como 
reservatório, nomeadamente no que respeita a seres humanos imunodeprimidos. Embora seja 
de extrema importância fazer o despiste de MRSA, alargá-lo a toda a população equina e ao 
pessoal que com ela trabalha pode ser economicamente inviável. Este facto reforça a 
importância acrescida de um estudo mais aprofundado da população do nosso país, de forma a 
poder formular algumas directrizes com vista à elaboração de guidelines, as quais, de futuro, 
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[First case of a cutaneous infection by a methicillin-resistant Staphylococcus simulans in a 
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Apesar do Staphylococcus intermedius ser o agente patogénico mais frequente na piodermite 
canina, os estafilococos coagulase negativos (ECNs), também têm sido associados a infecção 
cutânea quer no homem quer no cão (Medleau et al., 1986). Neste trabalho descrevemos um 
caso de piodermite superficial causada por uma estirpe multirresistente de Staphylococcus 
simulans num Teckel atópico. 
O cão apresentou-se à consulta no início de 2005 com problemas dermatológicos crónicos. 
Foi diagnosticada uma dermatite atópica complicada por uma piodermite secundária grave. O 
perfil de sensibilização incluía os grupos de fungos (Malassezia pachydermatis), penas 
(psitacídeos) e ácaros do pó e de armazenamento. A gravidade da atopia foi avaliada através 
do CADESI 02, tendo-se obtido um valor de 187, compatível com um quadro severo. Um ano 
após o diagnóstico de atopia em presença de um quadro de piodermite superficial, foi feita 
citologia cutânea e colheita para exame microbiológico. A citologia confirmou o quadro de 
piodermite. Foi isolado S. simulans em cultura predominante em associação com Escherichia 
coli. A estirpe de S. simulans era resistente à oxacilina com uma CIM > 4 μg/ml e por PCR 
possuía o gene mecA. Este isolado era também resistente às fluoroquinolonas de 2ª, 3ª e 4ª 
geração, gentamicina, cotrimoxazol, tetraciclina, cloranfenicol, clindamicina, eritromicina e 
azitromicina. Foi instituído tratamento per os com cefadroxil e tópico com peróxido de 
benzoílo 2%.  
Apesar de não haver indicação para o tratamento das infecções por ECNs meticilina 
resistentes por qualquer antibiótico do grupo dos β-lactâmicos, a resposta à terapêutica 
combinada foi positiva provavelmente pelo componente tópico. O caso descrito difere de 
dados anteriores quanto à existência deste mecanismo de resistência em S. simulans isolados 
de cães (Lilenbaum et al., 2000). A epidemiovigilância da resistência à meticilina em 
medicina veterinária é uma preocupação mundial pelo seu potencial zoonótico. 
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hospital escolar da FMV – UTL  
[Frequency of colonization by methicillin-resistant coagulase-positive staphylococci in cats 
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A colonização por staphylococci coagulase-positivo (SCP), em particular SCP meticilina 
resistente (SCPMR) é extremamente relevante em termos de saúde pública e de controlo da 
infecção hospitalar.  
Foram realizadas zaragatoas nasais a 40 gatos de diversas idades e de ambos os sexos no 
internamento do hospital escolar da Faculdade de Medicina Veterinária de Abril de 2008 a 
Abril de 2009. Cada zaragatoa foi inoculada primeiro em meio de enriquecimento de Manitol 
selectivo para estafilococos e incubada a 37º C 24 horas e depois em agar Columbia. As 
colónias suspeitas (β-hemólise, cor amarela) foram semeadas Chrom ID MRSA (bioMérieux) 
durante 48 horas. Realizou-se um Multiplex-PCR para pesquisa do gene mecA, do gene nuc, e 
do gene 16S. As estirpes foram ainda caracterizadas pela coloração de Gram, prova da 
catalase e coagulase e identificação pelo sistema BBL Gram positive.  
Nesta amostra, 12,5 % (n=5) dos gatos testados apresentaram colónias hemolíticas possíveis 
SCP, 80 % (n=32) apresentaram outras colónias não hemolíticas e 7,5 % (n=3) não 
apresentaram qualquer tipo de colónias. Das 5 estirpes hemolíticas, 2 (5 %) foram 
caracterizadas como S. aureus meticilina resistente (MRSA) (nuc +, mecA +, 16S +), uma 
como S. aureus meticilina sensível (MSSA) (nuc +, 16S+), uma (2,5 %) como 
Staphylococcus intermedius meticilina resistente (MRSI) (mecA +, 16S +), uma como S. 
intermedius meticilina sensível (MSSI) (16S +). 
A frequência de colonização encontrada por SCPMR foi baixa e enquadra-se nos valores 
encontrados em outros Países. A detecção da colonização por staphylococci coagulase-
positivo é muito importante por estes poderem ser vectores de genes de resistência a 
antibióticos e pela gravidade das infecções que podem provocar.  
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Many authors have emphasized the importance of methicillin-resistant staphylococci carriage 
in companion animals, as these bacteria are emerging as a significant problem in veterinary 
medicine, including both animal and public health standpoints. The objective of this study 
was to investigate the frequency of methicillin-resistant S. aureus (MRSA) and methicillin-
resistant S. pseudintermedius (MRSP) carriage in a random sample of 40 cats and 146 dogs 
hospitalized in the Faculty of Veterinary Medicine Teaching Hospital, Lisbon. Nasal swabs 
were collected at the time of patient admission to the hospital and inoculated in 3 ml of an 
enrichment broth (Weese et al., 2006). After overnight incubation, 10 μl of bacterial 
suspension were inoculated in Columbia 5% blood sheep agar plates. Colonies were identified 
as coagulase-positive staphylococci based on colony morphology, ability to cause hemolysis, 





system. MRSA and MRSP carriage was screened by plating enrichment cultures on a 
selective medium, Chrom MRSA ID (bioMérieux) and suspected colonies were confirmed by 
PCR identification of mecA (http://www.crl-ar.eu). Presumptive S. aureus isolates were 
confirmed by PCR amplification of the nuc gene and discrimination between S. 
pseudintermedius and S. intermedius was done by restriction fragment length polymorphism 
(RFLP) analysis of pta. All isolates were tested by PCR for the presence of lukF/lukS genes 
encoding Panton-Valentine leukocidin (PVL). MRSA was only found in two cats (5%) and 
one dog (0.6%). Nine dogs carried MRSP (6%), whereas none of the cats was found to be 
positive. All isolates were PVL-negative. The results indicate that the relative risk of MRSA 
and MRSP carriage might vary between the two host species, with MRSP being more 
frequent among dogs and MRSA among cats. The observed MRSA carriage rates were not 
surprising considering the high prevalence of MRSA in humans in Portugal. As sampling was 
performed immediately after admission to the hospital, the observed MRSP carriage rate is 
likely to reflect the prevalence among dogs in the community. MRSP were first described in 
55 
 
Europe in 2006 and the relatively high MRSP carriage rate observed in dogs suggest that 
these bacteria are quickly spreading in the canine population of this country. 
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Annex V – Poster presented at the ASM-ESCMID Conference on Methicillin-resistant 
Staphylococci in Animals: Veterinary and Public Health Implications 2009 
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Methicillin-resistant Staphylococcus aureus (MRSA) have been increasingly reported in 
veterinary medicine. We hereby report a case of an MRSA skin infection associated with 
hepatocutaneous syndrome (HS) in a geriatric female dog, as well as the colonization of one 
of the attending veterinarians. An eleven year old female Labrador Retriever presented five 
years ago at a veterinary hospital in the Lisbon area with a chronic right forelimb 
pododermatitis and footpad hyperkeratosis. Leishmaniosis was diagnosed. Two episodes of 
acute onset hepatitis developed during leishmaniosis treatment with allopurinol and 
levamisol. Cutaneous lesions became exudative, ulcerative and purulent. Several courses of 
antimicrobial therapy allowed temporary remission. The infection extended to the other paws 
and ano-genital skin. A fistulae swab was cultured. S. aureus was isolated in predominant 
culture along with Enterobacter cloacae. Antimicrobial susceptibilities were determined by 
the disk diffusion method and by minimal inhibitory concentration with DADE MicroScan 
panels and interpreted according to CLSI guidelines M31-A3 and M100-S17. MRSA nasal 
carriage by the attending vet was evaluated three weeks after exposure. The two MRSA 
isolates were identified by PCR for the mecA gene, subjected to staphylococcal protein A 
typing (spa), staphylococcal cassette chromosome mec typing, and underwent multilocus 
sequence typing (MLST). Isolates were also tested for the lukF/lukS genes encoding Panton-
Valentine leukocidin (PVL). The animal and human MRSA isolates were identified as ST22, 
spa type t032 and SCCmec IV. None of the MRSA isolates carried the PVL genes. The 
isolates were also resistant to fluoroquinolones (enrofloxacin, marbofloxacin, ciprofloxacin, 
levofloxacin) and susceptible to aminoglycosides (gentamicin, tobramycin, netilmicine, 
amikacin), chloramphenicol, trimethoprim-sulfamethoxazole, and vancomycin. The E. 
cloacae was resistant to amoxicillin, amoxicillin-clavulanate, cephalexin, cefuroxime and 
tetracycline. Treatment with gentamicin 5 mg/kg IM sid was carried out for five days. 
Although therapy was performed the cutaneous infection aggravated and clinical condition 
worsened. The owner asked for euthanasia. MRSA are an important cause of human 
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nosocomial infections in Portugal. It seems that this dog’s MRSA infection may be 
community acquired, possibly through the owner or transmitted through the environment. The 
severity of the footpads skin lesions, associated with the HS and the previous antimicrobial 
usage may have predisposed to the MRSA infection. To our knowledge, this is the first report 
of the epidemic clone EMRSA-15 in a dog in Portugal. 
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Annex VI – Poster presented at the ASM-ESCMID Conference on Methicillin-resistant 
Staphylococci in Animals: Veterinary and Public Health Implications 2009 
High-frequency of clindamycin associated resistance among MRSA CC398 from 
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Recent evidence of a community-acquired methicillin-resistant Staphylococcus aureus case of 
invasive infection caused by MRSA ST398 multi-resistant strain of swine origin in a pig-farm 
worker in Cremona, Italy, reinforces the emerging problem of animal MRSA as a human 
occupational health hazard (Pan et al., 2009). The aim of this study was to characterize the 
antimicrobial susceptibility of MRSA strains isolated during the Portuguese European Union 
baseline study for the detection of MRSA in breeding pigs. Dust swabs were taken from 171 
randomly selected breeding and production pig farms from distinct regions of Portugal. 
MRSA isolates were identified by polymerase chain reaction (PCR) for the mecA gene 
(http://www.crl-ar.eu), subjected to staphylococcal protein A (spa) (http://www.seqnet.org/) 
typing, and a new variant underwent multilocus sequence typing (MLST) 
(http://www.mlst.net). Isolates were also tested for the lukF/lukS genes encoding Panton-
Valentine leukocidin (PVL). Antimicrobial susceptibilities were determined by minimal 
inhibitory concentration with DADE MicroScan panels, and interpreted according to CLSI 
guidelines M31-A2 and M100-S17. Dust swabs from 21 herds tested positive for MRSA. The 
MRSA isolates from Portuguese herds were all identified as CC398 with spa types t108 
(n=12), t011 (n=7), and t1255 (n=1), except for a newly identified ST398 spa variant named 
t4854. None of the MRSA isolates carried the PVL genes. Susceptibility testing revealed 
resistance to tetracycline in all MRSA isolates. Seven isolates of the 21 were resistant to 
clindamycin only and 6 both to clindamycin and erythromycin. Eight isolates were resistant to 
trimethoprim/sulfamethoxazole. Two strains were gentamicin resistant. One strain was 
resistant to all fluoroquinolones tested (ciprofloxacin, gatifloxacin, levofloxacin, and 
moxifloxacin), and also chloramphenicol. All isolates were susceptible to mupirocin, 
fosfomycin, fusidic acid, rifampin, nitrofurantoin, linezolid, quinupristin/dalfopristin, 
teicoplanin and vancomycin. The occupational hazard for livestock associated MRSA 
colonization through the intensity of pig contact has been confirmed. Recent evidence-based 
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guidelines for the prophylaxis and treatment of human MRSA skin and soft tissue infections 
(Gould et al., 2009) include the use in monotherapy or eradication therapy of tetracyclines, 
clindamycin and trimethoprim/sulfamethoxazole. The high frequency of resistance found in 
this study towards these antimicrobials in CC398 MRSA of animal origin is important. 
Further studies are required to elucidate the mechanism of resistance towards clindamycin 
with macrolide susceptibility in these isolates. The emergence of associated resistance in 
MRSA animal isolates is a concerning fact for the pig industry, compromising antimicrobial 
therapy of possible human or animal infections. 
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Annex VII – Poster presented at the VI OMV Conference 2009 
Frequência de colonização por staphylococci coagulase-positivo meticilina-resistente em 
cães internados no hospital escolar da FMV – UTL 
[Frequency of colonization by methicillin-resistant coagulase-positive staphylococci in dogs 
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Os staphylococci coagulase-positivos meticilina resistentes, particularmente Staphylococcus 
aureus (MRSA) e Staphylococcus pseudintermedius (MRSP), são agentes oportunistas de 
grande importância. Estes organismos têm vindo a ser relatados com cada vez mais frequência 
em cães, o que os torna relevantes em termos de saúde animal e pública. O objectivo deste 
estudo baseou-se na investigação da frequência de colonização por MRSA e MRSP em cães 
internados no Hospital Escolar da Faculdade de Medicina Veterinária.  
Foram realizadas zaragatoas nasais a 146 cães de diversas idades e de ambos os sexos no 
internamento do hospital escolar de Abril de 2008 a Abril de 2009. Cada zaragatoa foi 
inoculada primeiro em meio de enriquecimento de manitol selectivo para estafilococos e 
incubada a 37ºC 24 horas e depois em agar Columbia. As colónias suspeitas (β-hemólise, cor 
amarela) foram semeadas Chrom ID MRSA (bioMérieux) durante 48 horas. A resistência à 
meticilina foi confirmada por amplificação do gene mecA por PCR. Os possíveis isolados de 
S. aureus foram confirmados por amplificação do gene nuc e a diferenciação entre S. 
intermedius e S. pseudintermedius foi feita por análise do gene pta por RFLP. As estirpes 
foram ainda caracterizadas pela coloração de Gram, prova da catalase e coagulase e 




. Todos os isolados foram testados por PCR para 
a presença dos genes lukF/lukS que codificam a leucocidina Panton-Valentine (PVL). 
Nesta amostra, 0,6 % (n=1) dos cães testados apresentaram MRSA e 6% (n=9) MRSP. Todos 
os isolados eram PVL negativos.  
Os resultados revelam que o risco de colonização por MRSP é superior ao risco de 
colonização por MRSA. Como a amostra foi colhida durante a admissão ao internamento, a 
frequência de colonização por MRSP reflecte a sua prevalência nos cães na comunidade. 
Tendo em conta que o primeiro MRSP descrito na Europa foi em 2006, a elevada frequência 
encontrada neste estudo indica que esta bactéria se está rapidamente a disseminar pela 
população canina do país. 
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Annex VIII –Paper article submitted and accepted to the Journal of Feline Medicine and 
Surgery 
Treatment of a lower urinary tract infection in a cat caused by a multidrug-methicillin-
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Staphylococci and enterococci are common causes of urinary tract infections in cats. 
However, both species are rarely implicated together as causes of lower urinary tract 
infections associated with urethral obstruction. This report describes the first case of a 
multidrug-methicillin-resistant Staphylococcus pseudintermedius belonging to spa type t06 
and Enterococcus faecalis urinary infection in a cat with pre-existing and recurrent urethral 
obstruction. Both species were isolated at >10
5
CFU/ml from cystocentesis urine specimen. 
Clinical and ultrasound features, results from urinalysis, urine culture, molecular typing and 
susceptibility testing by minimal inhibitory concentrations determination are described. Oral 
treatment with nitrofurantoin was the only antimicrobial agent that constituted a viable 
therapeutical option and had a positive outcome. 
 
A 5-year-old, neutered male Persian cat, living in an apartment was presented with urethral 
obstruction. The cat was fed a commercial dry cat food. The owner reported a 4-day history of 
inappetence, reduced water intake, dysuria, stranguria and constipation and generalized 
weakness. On physical examination, its bladder was enlarged and painful and the cat appeared 
depressed. Blood samples were taken for routine laboratory evaluation. The CBC revealed 
mild leucocytosis (20.5x 10
3
/ L, reference range 3.8-19x 10
3
/ L) with neutrophilia (18,655, 
reference range 1290-15 950/ L) and all red blood cell parameters were within reference 
range. Serum biochemical analysis revealed severe azotemia (BUN, > 300 mg/dL, reference 
range 10-30 mg/dL; Creatinine > 10 mg/dL, reference range 0.8-2.0 mg/dL) and 
hyperkalaemia (Potassium 9.6 mmol/L, reference range 3.5-5.1 mmol/L). Tests for feline 
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leukaemia virus and feline immuno-deficiency virus were negative (Snap Combo FeLV 
Ag/FIV Ab Test Kit, Idexx Labs.). The cat was treated with diazepam (Diazepam; Intervet, 
0.2 mg/kg, IV) and butorphanol (Torbugesic, Fort Dodge) at the dosage of 0.4mg/kg and a 
sterile catheter was passed through the urethra to the bladder, and then sutured to the perineal 
skin. Haemorrhagic urine was removed and analysed (see Table 1). Urinalysis revealed pH 
7.0 and the absence of crystalluria. The cat was treated with intravenous physiological saline 
solution 0.9% to resolve the post-renal uraemia and hyperkalaemia, ranitidine (Zantac; 
GlaxoSmithKline, 2 mg/kg, bid, IV) to reduce gastric acidity, and butorphanol (0.4 mg/kg, 
tid, IM) ensured analgesia. On day 3, the urethral catheter was removed and the cat was seen 
to urinate on its own. Haematology and serum biochemistry parameters were within reference 
ranges. After catheterization, an antimicrobial treatment course of amoxicillin combined with 
clavulanic acid (Synulox, Pfizer) at the dose of 12.5 mg/Kg body weight, twice daily, for one 
week was instituted. The cat was discharged from the hospital with feline URINARY SO® 
diet. On day 15 the cat was re-evaluated for persistent haematuria, pollakiuria and stranguria 
due to a partial urethral obstruction. The urinalysis was compatible with inflammation in the 
absence of bacterial infection (Table 1). Abdominal ultrasound examination detected acoustic 
shadowing in the bladder consistent with cellular debris, but no calculi, mass, thickening or 
mineralisation of the wall was observed. The left kidney had normal form, size, and 
echogenicity. The right kidney had a cystic cortical lesion.The prescription diet was 
maintained and flavoxate hydrochloride was prescribed (50mg, PO, bid) for urethral spasm 
control. On day 23 a second complete urethral obstruction occurred, this time with a 
urinalysis compatible with lower urinary tract infection (LUTI). Urine culture was performed 
with a sample obtained by cystocentesis. A mixed LUTI was found caused by Staphylococcus 
pseudintermedius (>10
5
CFU/ml) and Enterococcus faecalis (>10
5
CFU/ml) isolates. 
Antimicrobial susceptibility testing was performed using the microbroth dilution method 
(DADE Behring Microscan PM21, USA), and interpreted according to CLSI guidelines M31-
A3 and M100-S17 (CLSI 2008, 2007) (Table 2). Discrimination between S. pseudintermedius 
and S. intermedius was done by pta PCR- restriction fragment length polymorphism analysis 
(Bannoehr et al 2009). Methicillin resistance in S. pseudintermedius was confirmed by PCR 
detection of mecA (http://www.crl-ar.eu). The methicillin-resistant S. pseudintermedius 
(MRSP) harbored a SCCmec V cassette using MPCR1 and MPCR2 described by Kondo et al 
(2007), was PVL negative (Lina et al 1999), and had spa type t06 (repeat sequence 
r01r02r03r03r06r05) (Moodley et al. 2009).  
Possible therapeutic options were based on the following principles: i) both strains had to be 
susceptible to the antimicrobial agent; ii) the agent had to have good pharmacodynamic and 
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pharmokinetic characteristics for use in LUTI; iii) the antimicrobial agent could not be one of 
the critically important antimicrobials for human medicine (FAO/OIE/WHO, 2008). 
Nitrofurantoin was the only antimicrobial to fit all three criteria (Table 2), and was prescribed 
at 4 mg/kg, tid, for 60 days (one fourth of the content of a 100mg capsule was administrated 
PO after dilution in 5 mL of water with a syringe). The motivated owners of the cat were a 
veterinary student and her mother. This ensured compliance. There were clear signs of clinical 
improvement after 5 days and further urine samples collected on days 5, 20, 25 and 60 after 
commencing nitrofurantoin treatment were culture negative (Table 1). However, on day 51 
after the first episode of urethral obstruction, a third episode of total obstruction occurred 
(Table 1), and was not related to the LUTI but probably due to the underlying presence of a 
feline idiopathic cystitis obstructive form. This required a perineal urethrostomy to alleviate 
the obstruction.  
Obstructive idiopathic cystitis (OIC) constitutes a common medical problem of the lower 
urinary tract in male cats and Persian cats appear to be predisposed (Gunn-Moore 2003, 
Eggertsdóttir et al 2007). Urethral obstruction in cats may be present with a concurrent 
urinary tract infection at the time of obstruction relief (Eggertsdóttir et al 2007). Risk factors 
for the occurrence of a LUTI secondary to OIC remain to be elucidated. In a retrospective 
case-control study at three veterinary referral hospitals significant risk factors for the 
acquisition of a methicillin-resistant Staphylococcus aureus infection compared to a 
methicillin-susceptible Staphylococcus aureus infection was the presence of a urinary catheter 
or co-infection (Faires and Weese 2008). The third consecutive urethral obstruction in our cat 
was associated with the presence of a mixed LUTI with a multi-drug resistant MRSP. In our 
case, repeated bladder over-distension and urinary catheterisation may have predisposed to 
LUTI. The lack of a closed collection system at the time of the urinary catheterisation and the 
use of antimicrobial therapy during and after the first catheterisation procedure could have 
been contributing risk factors for the LUTI. Antimicrobials and their selective pressure have 
already been implicated in companion animal MRSP infection or colonization (Sasaki et al 
2007). The systematic utilization of sterile closed collection systems attached to urethral 
catheters may overcome the occurrence of a LUTI secondary to OIC and result in 
antimicrobial prudent usage. 
The recent clonal spread of MRSP in Europe is largely due to the emergence of a single clone 
(t02, ST71, SCCmec II-III) (Moodley et al 2009, Kadlec et al 2009). Spa type t06 and 
SCCmec V identical to those found in our MRSP, are associated with an MRSP clone 
currently circulating in North America (t06, ST68, SCCmec V) (Black et al 2009, Moodley et 
al 2009). In addition to β-lactam resistance, resistance in this isolate was observed to five 
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antimicrobial classes; fluoroquinolones, lincosamides, macrolides, aminoglycosides and 
trimethoprim/sulfamethoxazole. Susceptibility was observed to tetracycline and 
chloramphenicol. This susceptibility pattern is also observed in the ST68 MRSP U.S.A. clone 
but not in the European one (Andersson et al 2009). The MRSP causing LUTI in our patient is 
related to the ST68 clone which is a common cause of LUTI and pyoderma in the U.S.A. 
The E. faecalis also involved in the LUTI was ampicillin susceptible and exhibited low-level 
gentamicin resistance which is common in Portugal and in other European countries (Delgado 
et al 2007, Damborg et al 2008). Therapeutic problems associated with enterococcal 
infections are often the result of intrinsic resistance of this genus towards cephalosporins, 
penicillinase-resistant penicillins, polymyxines, low concentrations of aminoglycosides, 
clindamycin, fluoroquinolones, streptogramines (E. faecalis) and 
trimethoprim/sulfamethoxazole. 
This case report describes for the first time a co-infection with a multidrug-MRSP and E. 
faecalis in a feline lower urinary tract infection with pre-existing and recurrent urethral 
obstruction. In Switzerland, multidrug-resistant MRSP were previously found as a single 
causative pathogen in three cats with urinary tract infection (Wettstein et al 2008). The multi-
resistance profile of MRSP strains spreading in Europe and North America typically includes 
resistance to all oral antimicrobials routinely used for treatment of infections in small animal 
medicine. In the present case report, therapeutic choices were even further narrowed by the 
co-infection. Nitrofurantoin usage is not authorized in animals. However, the rational for its 
use was the avoidance of using one of the critically important antimicrobials in human 
medicine, e.g. vancomycin. Infections with MRSP represent a real therapeutic challenge. The 
increased pressure to use last resort antimicrobials that are saved for the treatment of serious 
human infections raises important ethical questions that demand revision of regulatory and 
preventive measures to control this important animal health problem. 
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TABLE 1. Urinalysis and urine culture results during treatment and follow-up 






Day 15 Day 23 
(2
nd
 urethral obstruction and 
LUTI) 
Day 31 




days from LUTI 
diagnosis) 
Day 46 
(20 days after 














(60 days after 
the beginning of 
nitrofurantoin 
treatment) 
Specific gravity (1035-1060) 1037 1035 1015 1010 1030 1035 1020 
pH (6-7) 7 7 7,5 8 6 7 6,5 
Protein (0 to trace) mg/dl 
300 > 2000 300 low negative 300 negative 
Glucose (negative) negative negative negative negative negative negative negative 
Bilirubin (negative) negative negative negative negative negative negative negative 
RBC/HPF (<5) > 300 40 to 50 > 300 rare 0 to 1 > 300 1 to 2 
WBC/HPF (<5) 0 to 1 0 to 1 8 to 10 0 1 to 2 2 0 to 1 
Crystals (none) none none none none none none none 
Epithelial cells (occasional) rare rare occasional occasional rare rare rare 
Bacteria (none if cystocentesis 
used) 















negative negative negative negative 
RBC/HPF, Red blood cell average count under high power field (400X); WBC/HPF, white blood cell average count under high power field (400X) 
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TABLE 2. In vitro activity of twenty-eight selected antimicrobial agents tested against uropathogenic bacterial strains and possible therapeutical 
options 
Antimicrobial Agent 





   
Combined  Possible  
MIC (μg/ml) MIC (μg/ml) MRSP /E. faecalis  therapeutical  
 Clinical breakpoints  Clinical breakpoints MIC interpretation  
options for  
  Susceptible Resistant   Susceptible Resistant   UTI treatment  
Amoxicillin-Clavulanic Acid 4/2 ≤ 4/2 ≥ 8/4 - NA NA R No 
Ampicillin > 8 ≤ 0.25 ≥ 0.5 < 0.25 ≤ 8 ≥ 16 R No 
Azithromycin > 4 ≤ 2 ≥ 8 - NA NA R NoA 
Cefotaxime < 0.5 ≤ 8 ≥ 64 - NA NA R No 
Chloramphenicol 8 ≤ 8 ≥ 32 8 ≤ 8 ≥ 32 S NoA 
Ciprofloxacin > 2 ≤ 1 ≥ 4 > 2 ≤ 1 ≥ 4 R No 
Clindamycin > 2 ≤ 0.5 ≥ 4 - NA NA R NoA 
Erythromycin > 4 ≤ 0.5 ≥ 8 > 4 ≤ 0.5 ≥ 8 R No 
Fosfomycin < 32 ≤ 32 > 32 - NA NA S NoB 
Fusidic Acid < 2 ≤ 2 ≥ 32 - NA NA S NoB 
Gatifloxacin 4 ≤ 2 ≥ 8 - NA NA I NoB 
Gentamicin > 8 ≤ 4 ≥ 16 - NA NA R No 
Gentamicin High Level - NA NA < 500 < 500 ≥ 500 S NA 
Levofloxacin 4 ≤ 2 ≥ 8 > 4 ≤ 2 ≥ 8 R NoB 
Linezolid 2 ≤ 4 > 4 < 1 ≤ 2 ≥ 8 S NoB 
Moxifloxacin 0.5 ≤ 0.5 ≥ 2 > 2 ≤ 1 ≥ 2 R NoB 
Mupirocin < 4 ≤ 4 ≥ 256 - NA NA S NA 
Netilmicin 8 ≤ 8 ≥ 32 - NA NA S NoB 




a > 4 ≤0,25 ≥ 0,25 - NA NA R No 
Penicillin > 8 ≤ 0.12 ≥ 0.25 2 ≤ 8 ≥ 16 R No 
Quinupristin- Dalfopristin < 0.5 ≤ 1 ≥ 4 > 2 ≤ 1 ≥ 4 R NoB 
Rifampin < 0.5 ≤ 1 ≥ 4 2 ≤ 1 ≥ 4 I NoB 
Streptomycin High Level - NA NA < 1000 < 1000 ≥ 1000 S NoA 
Teicoplanin < 1 ≤ 8 ≥ 32 < 1 ≤ 8 ≥ 32 S NoB 
Tetracycline < 2 ≤ 4 ≥ 16 > 8 ≤ 4 ≥ 16 R No 
Trimethoprim/Sulfamethoxazole > 2/38 ≤ 2/38 ≥ 4/76 - NA NA R No 
Vancomycin 2 ≤ 2 ≥ 16 2 ≤ 4 ≥ 32 S NoB 
 
a
 according to the new clinical breakpoints for S. pseudintermedius (Bemis et al 2009) 
NA - not applicable; No – therapy not possible due to antimicrobial resistance; NoA – therapy not applicable due to pharmacodynamic and 
pharmacokinetic antimicrobial agent characteristics; NoB - critically important antimicrobial agents for humans as categorized by the Joint 
FAO/WHO/OIE Expert Meeting on Critically Important Antimicrobials Report (FAO/OIE/WHO, 2008). 
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Abstract 
Colonization and infection with methicillin-resistant Staphylococcus aureus (MRSA) and 
methicillin-resistant Staphylococcus pseudintermedius (MRSP) in companion animals is an 
emerging and significant problem in veterinary medicine. During one year, nasal swabs were 
obtained from cats and dogs admitted to the Teaching Hospital of the Faculty of Veterinary 
Medicine, Lisbon. Forty cats and 146 dogs were swabbed immediately. MRSA and MRSP 
colonization was screened by plating enrichment cultures on a selective medium, Chrom 
MRSA ID. Bacterial species and mecA were confirmed by PCR. Clonality of the isolates was 
assessed by pulsed-field gel electrophoresis (PFGE). All isolates were subjected to spa and 
SCCmec typing. They were also tested by PCR for the lukF/lukS genes encoding Panton-
Valentine leukocidin (PVL) in S. aureus and Luk-I and Staphylococcus intermedius 
exfoliative toxin (SIET) in S. pseudintermedius. MRSA was found in two cats (5 %) and one 
dog (0,6 %). Isolates were spa type t032, SCCmec IV and shared identical PFGE profiles. 
These were similar to the EMRSA-15 human clone. Strains were co-resistant to all 
fluoroquinolone and were PVL-negative. Nine dogs carried MRSP (6 %), whereas none of the 
cats was positive. PFGE cluster B grouped European MRSP isolates (CC71-MRSP-III) (n=8), 
while the PFGE type A strain (n=1) showed identical characteristics as the American MRSP 
clone strains (CC68-MRSP-V). All isolates were SIET negative. The 8 European MRSP 
isolates were positive for the luF/lukS genes and the American MRSP isolate was negative for 
both genes. Strains were multidrug-resistant, which represents a major challenge for 
veterinarians in terms of antibiotic therapy. 
 
 Keywords: colonization, companion animals, methicillin resistance, Staphylococcus aureus, 
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 Staphylococcus pseudintermedius 
 
1. Introduction 
 Coagulase positive staphylococci, particularly Staphylococcus aureus and Staphylococcus 
pseudintermedius are major important pathogens in Veterinary Medicine, which can be 
isolated from various body sites of healthy animals (Hanselman et al., 2008; Griffeth et al., 
2008; Weese and van Duijkeren, 2009). However, many opportunistic infections can develop, 
including pyoderma, otitis, wound infections, surgical site infections and urinary tract 
infections (Weese and van Duijkeren, 2009). The rising isolation of antibiotic resistant strains 
in household pets raises the concern for public health (van Duijkeren et al., 2004; Baptiste et 
al., 2005; Loeffler et al., 2005; O’Mahony et al., 2005; Hanselman et al., 2008; Loeffler et al., 
2007; Wettstein et al., 2008; Weese and van Duijkeren, 2009; Perreten et al., 2010; Ruscher et 
al., 2010). Epidemiological studies have revealed the occurrence of indistinguishable clones 
in animals and in humans: e.g. CMRSA-5, EMRSA-15 and EMRSA-16 are major human 
epidemic clones that have been isolated from dogs and cats (Baptiste et al., 2005; Loeffler et 
al., 2005; O’Mahony et al., 2005; Hanselman et al., 2008). 
Methicillin-resistant Staphylococcus aureus (MRSA) is a major world nosocomial pathogen 
in humans and methicillin-resistant Staphylococcus pseudintermedius (MRSP) has already 
been implicated in human infections (Van Hoovels et al., 2006; Chuang et al., 2010). 
Unfortunatelly, these MRSP isolates from humans were not characterized genetically and we 
do not know their relation to the animal clones. Furthermore MRSA and MRSP often express 
a multidrug-resistant pattern (van Duijkeren et al., 2004; Baptiste et al., 2005; Moodley et al., 
2009; Wettstein et al., 2008; Ruscher et al., 2010) which narrows therapeutic options in 
already complicated infections and serve as reservoirs of antimicrobial resistance genes that 
can be transferred from pet animals to humans. This transmission of antimicrobial resistance 
might be enhanced by the fact that pet animals are in close physical contact with humans, with 
touching, petting and licking occurring at high frequency and animals being considered as 
part of the family (Guardabassi et al., 2004). Another important fact is the prescription of the 
same classes of antimicrobial agents in human medicine and in small animal practice, like 
penicillins, cephalosporins, quinolones, tetracyclines, aminoglycosides and macrolides 
(Guardabassi et al., 2004). All these classes of antimicrobial agents are considered critically 
important for both human and veterinary medicine (FAO/OIE/WHO, 2008), which raises the 
problem of prudent use of antimicrobials. 
Data on MRSA and MRSP colonization in cats is scarce, particularly in Europe. Furthermore, 
data on clonality and genotypic characteristics of MRSP colonization isolates recovered from 
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pets is also limited. The primary objective of the study was to investigate the frequency of 
MRSA and MRSP colonization in cats and dogs hospitalized at the Teaching Hospital of the 
Faculty of Veterinary Medicine, Lisbon. The second objective was to characterize the 
possible isolates by molecular methods and relate them with previous described epidemic 
clones as well as their possible pathogenic potential (prevalence of the PVL toxin in S. aureus 
and Luk-I and SIET in S. pseudintermedius). 
 
2. Material and Methods 
2.1 Sampling and collection of data on antimicrobial treatment 
 During a one year study (from April 2008 to April 2009), nasal swabs were obtained 
immediately or at the most two hours after admission from cats and dogs entering the 
Teaching Hospital of the Faculty of Veterinary Medicine. Forty cotton swabs from cats and 
146 from dogs were rolled on the nasal mucosae of both nostrils and were immediately 
processed at the laboratory. 
 
2.2 Bacterial isolation and characterization 
2.2.1 Strains isolation 
The nasal swabs were inoculated in 3 ml of an enrichment broth consisting of 10 g/l mannitol, 
65 g/l NaCl, 2,5 g/l yeast extract and 10 g/l tryptone (Vengust et al., 2006). After overnight 
incubation, 10 μl of bacterial suspension were inoculated in Columbia 5% blood sheep agar 
plates (bioMérieux, Marcy l’Etoile, France). Colonies were identified as coagulase-positive 
staphylococci based on colony morphology, ability to cause hemolysis, gram straining, 




 typing system. 
 
2.2.2 Methicillin resistance confirmation 
MRSA and MRSP colonization was screened by plating 112 enrichment cultures on a 
selective medium, Chrom MRSA ID (bioMérieux) and suspected colonies were confirmed by 
PCR to have the mecA gene (http://www.crl-ar.eu). 
 
2.2.3 Species confirmation 
 Presumptive S. aureus and S. pseudintermedius isolates were confirmed by PCR 
amplification of the nuc gene (http://www.crl-ar.eu; Sasaki et al., 2010) and discrimination 
between S. pseudintermedius and S. intermedius was further investigated by restriction 




 2.2.4 PVL, Luk-I and SIET detection 
All MRSA isolates were tested by PCR for the presence of lukF/lukS genes encoding PVL 
using the primers described by Lina et al., 1999. All MRSP isolates were tested by PCR for 
the presence of lukF/lukS genes encoding Luk-I using the primers described by Futagawa-
Saito et al. (2004) and the detection of SIET was carried out using primers described by Lautz 
and colleagues in 2006. 
 
 2.3 spa Typing 
For MRSA, the primers used for spa typing were those recommend by the European 
UnionReference Laboratory of Antimicrobial Resistance (http://www.crl-ar.eu), and spa types 
were assigned through the Ridom web server (http://www.ridom .de/spaserver/). 
For MRSP, spa typing was performed according to Moodley et al. (2009) and the sequences 
were interpreted manually according to the criteria proposed by the same author. 
 
 2.4 Staphylococcal Cassette Chromosome mec (SCCmec) Typing 
SCCmec types were determined using the multiplex PCR 1 and the multiplex PCR 2 
accordingly to Kondo and collaborators (2007). The molecular weight of each PCR amplicon 
was determined and assigned to a particular allele type in each strain. The combination of the 
type ccr and mec complex was used to consign SCCmec types. 
 
2.5 Antimicrobial Susceptibility Testing 
Antimicrobial susceptibility testing was performed by the disk diffusion method. The results 
were registered after incubation at 37˚ C for 18h, measuring the diameter of the zone of 
inhibition, if present, for each antibiotic used. Inhibition zone diameters were interpreted 
according to the Clinical Laboratories Standards Institute clinical breakpoints for animals 
(CLSI, 2008) and, when breakpoints were unavailable for bacteria of animal origin, according 
to the human CLSI breakpoints (CLSI, 2009). For fusidic acid and mupirocin, inhibition zone 
diameters were interpreted using breakpoints proposed by Toma and Barriault (1995) and 
Fuchs et al. (1999), respectively. Susceptibility test breakpoints for oxacillin of S. 
pseudintermedius were those described by Bemis et al. (2009). For MRSA and MRSP, the 
following antimicrobial discs (Oxoid, Hampshire, United Kingdom) were used: amikacin (30 
μg), cephalothin (30 μg), chloramphenicol (30 μg), ciprofloxacin (5 μg), clindamycin (2 μg), 
enrofloxacin (5 μg), erythromycin (15 μg), fusidic acid (10 μg) gentamicin (10 μg), 
kanamycin (30 μg), levofloxacin (5 μg), linezolid (30 μg), marbofloxacin (5 μg), 
moxifloxacin (5 μg), mupirocin (5 μg), nitrofurantoin (300 μg), norfloxacin (10 μg), ofloxacin 
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(5 μg), oxacillin (1 μg), penicillin G (10 units), quinupristin/dalfopristin (15 μg), rifampicin (5 
μg), tetracycline (30 μg), trimethoprim (5 μg), and vancomycin (30 μg). MRSA was also 
tested for cefoxitin (30 μg) susceptibility, since cefoxitin has been recently used to replace 
oxacillin in the phenotypic identification of MRSA isolated from humans (CLSI, 2009). 
 
2.6 Pulsed-Field Gel Electrophoresis (PFGE) 
PFGE was performed as described by Murchan et al. (2003) with minor modifications. 
Briefly, bacterial cultures were grown overnight in brain heart infusion broth (BD Difco, New 
Jersey, USA) and were incorporated into 2 % (w/v) agarose discs, instead of plugs. After four 
hours lysis with lysostaphin (5 mg/ml), lysozyme (100 mg/ml) and RNase (32,5 mg/ml) at 37º 
C, the discs were incubated with proteinase K (20 mg/ml) overnight at 56º C and one disc was 
digested with SmaI (20 U/ml) overnight at room temperature. PFGE was performed by 
clamped homogeneous electric field (CHEF) electrophoresis with a CHEF-DR III System 
(Bio-Rad Laboratories, San Diego, USA) in a 1,1 % (w/v) agarose gel with a pulsing switch 
time of 2-5 s at 5,6 V/cm for 24 h for MRSP and pulsing switch time of 5-15 s at 6 V/cm for 
10 h followed by pulsing switch time of 15-60 s at 6 V/cm for 13 h for MRSA. EMRSA-15 
and American MRSP clones, previously isolated in Portugal (Pomba et al., 2009; Pomba et 
al., 2010), were used as reference 176 strains and included in the gel. The gels were inspected 




Twelve methicillin-resistant staphylococci were isolated from the nose of ten dogs and two 
cats out of a total of 186 animals screened. One hundred forty six animals were dogs (78 %) 
and only forty were cats (22 %). Males were the predominant gender sampled (49 %), 
followed by females (31 %), females castrated (14 %) and males castrated (6 %). One 
hundred seventeen animals (63 %) had received antimicrobial treatment within the month 
prior to sampling and forty nine animals (26 %) had received antimicrobial treatment within 
the year before sampling. Many classes of antimicrobials were prescribed, but the two classes 
more often selected were β-lactams and fluoroquinolones. The three animals carrying a 
MRSA isolate had received antimicrobial treatment the month before the nasal swab 
collection and one animal in the year before too (see Table 1). Six animals colonized with 
MRSP had received antimicrobial treatment one month previous to sampling and four one 
year before (see Table 1). 
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MRSP strains were identified in 9 dogs, with a frequency of 6 %. No MRSP were isolated 
from cats. Two pattern of resistance were seen: FMV 1 strain demonstrated resistance to 
oxacillin, gentamicin, kanamycin, ciprofloxacin, enrofloxacin, levofloxacin, marbofloxacin, 
moxifloxacin, norfloxacin, ofloxacin, erythromycin and trimethoprim (see Table 2); the other 
8 strains, FMV 2 to 9, demonstrated resistance to oxacillin, gentamicin, kanamycin, 
ciprofloxacin, enrofloxacin, levofloxacin, marbofloxacin, moxifloxacin, norfloxacin, 
ofloxacin, clindamycin, erythromycin, tetracycline and trimethoprim (see Table 2).One of the 
isolates, FMV 1, was spa type t06 belonging to the clonal complex (CC) 68 and the other 
eight, FMV 2 to 9, were t02 and consequently were CC71. According to Kondo and 
colleagues criteria (2007), isolate FMV 1 harbored a SCCmec type V (class C mec complex 
and ccrC recombinase) and the other 8 isolates, FMV 2 to 9, harbored a variant of the 
SCCmec type III (class A mec complex and ccrAB3 recombinase). All isolates were typeable 
with SmaI-PFGE, resulting in the detection of two PFGE clusters (A and B). The type B was 
subdivided into 3 subtypes (B1 to B3) (Table 3). The PFGE typing results were in agreement 
with those obtained by spa and SCCmec typing. PFGE cluster B grouped European MRSP 
isolates (CC71-MRSP-III), while PFGE type A strain showed identical characteristics as the 
American MRSP clone (ST68-MRSP-V) (see Table 3). All isolates were SIET-negative. The 
8 European MRSP isolates were positive for the luF/lukS genes and the 208 American MRSP 
isolate was negative for both genes. 
MRSA was found in two cats (5 %) and one dog (0.6%). Therefore, MRSA were the only 
staphylococci isolated from cats. The same pattern of resistance was seen for the three isolates 
(FMV 10, 11 and 12): oxacillin, ciprofloxacin, enrofloxacin, levofloxacin, marbofloxacin, 
moxifloxacin, norfloxacin and ofloxacin (see Table 2). Tandem repeat sequence analysis of 
the spa gene concluded that all isolates were t032 and thus belonged to the CC22. All isolates 
harbored SCCmec type IV (class B mec complex and ccrAB2 recombinase). A close relation 
to the European disseminated clone EMRSA-15 (CC22/ST22-MRSA-IV) was present: PFGE 
analysis revealed the same PFGE type (C) among the isolates, including with the previously 
described EMRSA-15 strain (ST22-MRSA-IV) causing skin infection in a dog and the 




The incidence of MRSA in Human Portuguese Hospitals remains one of the highest in 
Europe, with dominance of the EMRSA-15 clone (ST22-MRSA-IV) (Aires-de-Sousa et al., 
2008). Thus, it is not surprising that the MRSA colonization strains isolated from our 
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companion animals belong to this epidemic clone. Furthermore, MRSA ST22-SCCmec IV 
had been previously isolated from a skin infection in a dog and attending veterinarian in 
Portugal (Pomba et al., 2009). All isolates showed the same resistance profile as the epidemic 
EMRSA-15 (resistance to methicillin and ciprofloxacin). The origin of EMRSA-15 isolates in 
small animals remains unknown but several authors suggest that MRSA isolated from 
companion animals have a human source (Loeffler et al., 2005). As in our study, Loeffler and 
colleagues (2005) demonstrated the occurrence of EMRSA-15 in dogs in the United 
Kingdom, and pointed the epidemiological impact since it proves that this nosocomial 
pathogen is not restricted to hospitals and can be carried and disseminated by healthy humans 
and animals in the community. Little information is available to date on the risk of 
antimicrobial usage with regard to MRSA colonization in small animals (Catry et al., 2010). 
According to previous case reports, many animals infected or colonized with MRSA have 
been treated with antimicrobials prior to the diagnosis (Catry et al., 2010). Interestingly, our 3 
animals colonized with MRSA received antimicrobial treatment with amoxicillin-clavulanic 
acid one month prior to the nasal swab collection. Nevertheless, our sample is too small to 
prove antimicrobial administration was a risk factor and 63 % of non-colonized animals were 
also exposed to antimicrobial administration, including amoxicillin-240 clavulanic acid, 
without development of MRSA colonization. 
In 2009, the first MRSP infection was identified in Portugal. The isolate was the co-source 
(together with Enterococcus faecalis) of a lower urinary tract infection in a cat and after 
molecular characterization was found to be associated with the American MRSP clone (ST68-
MRSP-V) (Pomba et al., 2010). To that date, this clone had been exclusively reported in the 
United States of America and Canada. Furthermore, to the best of our knowledge we detected 
for the first time a case of colonization with the American MRSP clone (ST68-MRSP-V) in 
Europe. The isolation of a second strain belonging to this clonal complex raises the question if 
it is already spreading through the European continent, too. More studies should be conducted 
to identify the real prevalence of this clone in Portugal and other European countries. 
The European MRSP clone (ST71-MRSP-III) has been implicated as responsible for 
infections in companion animals in Germany, Sweden and Switzerland (Wettstein et al., 
2008; Moodley et al., 2009) and more recently was isolated also from clinical samples 
throughout Europe (Perreten et al., 2010; Ruscher et al., 2010). Interestingly, European MRSP 
isolates show a multidrug-resistant pattern (resistance to more than 4 antimicrobial classes), 
with resistance to some aminoglycosides, quinolones, lincosamides, macrolides, tetracyclines, 
and folate pathway inhibitors (trimethoprim) (Loeffler et al., 2007; Wettstein et al., 2008; 
Ruscher et al., 2009; Perreten et al., 2010; Ruscher et al., 2010) and therefore they should be 
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referred as multidrug-resistant S. pseudintermedius (MDRSP). The isolates in our study show 
exactly the same multidrug-resistant pattern. Surprisingly, our isolates show resistance not 
only to second and third generation quinolones, but also to a fourth generation 
fluoroquinolone, moxifloxacin, which has enhanced activity against gram-positive cocci (Ince 
et al., 2003). This is an interesting fact since moxifloxacin is not licensed for veterinary use 
and prescription in Human Medicine is licensed only for the treatment of respiratory and skin 
infections. Intorre et al. (2007) found moxifloxacin-bordeline-intermediate-resistant S. 
intermedius strains according to CLSI breakpoints and in 2009 resistance to moxifloxacin was 
described in 45 clinical strains out of 46 MRSP strains (Ruscher et al., 2009). Intorre and co-
workers (2007) found that resistance to the older fluoroquinolones was correlated with a 
double mutation in the quinolone-resistance-determining regions (QRDR) within the genes 
gyrA (subunit of DNA gyrase) and grlA (subunit of topoisomerase IV) and speculated that an 
additional alteration in grlA was necessary for fourth generation fluoroquinolone’s resistance. 
However the true mechanism of moxifloxacin-resistance in S. pseudintermedius remains 
unknown and further studies are required. This development of resistance to moxifloxacin and 
the observation of a multidrug-resistant pattern along European and American MRSP strains 
can indicate that these strains have a high capacity of mutation or can easily acquire mobile 
elements, like transposons or plasmids, encoding resistance genes. 
Wettstein and colleagues (2008) also found resistance to chloramphenicol in their European 
MRSP strains, but our isolates do not demonstrate chloramphenicol resistance. This multidrug 
resistance pattern represents a major challenge for veterinarians in terms of antibiotic therapy. 
Most of the drugs to which these bacteria remain susceptible are used off-label in small 
animal practice (like amikacin, chloramphenicol and nitrofurantoin), others are used for 
human decolonization (fusidic acid and mupirocin) and others are last-resort drugs in human 
medicine (linezolid, quinupristin/dalfopristin, rifampicin and vancomycin). Moreover, 
linezolid, quinupristin/dalfopristin and vancomycin are considered antimicrobial limited for 
therapy of multidrug-resistant S. aureus infections by the joint Report of the FAO/WHO/OIE 
Expert Meeting (FAO/OIE/WHO, 2008). Thus, this represents a serious ethical dilemma, 
even when applying the “cascade principle”. Since there are no guidelines for treatment of 
infections with these MDRSP, it is up to every veterinarian to decide which antimicrobial to 
use. Most infections with MDRSP are skin and wound infections, otitis externa, respiratory 
infections and urinary tract infections (UTIs). Biocides, like chlorhexidine, triclosan, Tris-
EDTA and benzoyl peroxide, have been recommended for topical use in superficial skin 
infections and otitis externa. This approach is very successful and does not seem to select for 
antimicrobial resistance (Guardabassi et al., 2009). However, care should be taken in order to 
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also avoid development of resistance to biocides. Treatment of respiratory infections and 
UTIs with these MDRSP will be far more complicated to solve and precautions should be 
taken when choosing the antimicrobial therapy. 
The presence of Luk-I and SIET in MRSP CC71 has been previously described by Ruscher 
and colleagues in 2010. Our strains were SIET-negative but Luk-I-positive. Luk-I shows a 
strong toxicity on various polymorphonuclear cells, including human leukocytes, but only a 
slight hemolytic activity on rabbit erythrocytes (Futagawa-Saito et al., 2004). Because 
phagocytosis by polymorphonuclear cells is an important defense mechanism of the host, 
Luk-I may play a primary role in bacterial evasion to the host defense mechanisms, enhancing 
the opportunity of the cocci to colonize and set up an infection. Nevertheless the exact role by 
which Luk-I enables staphylococci colonization and infection is not completely understood 
and so its true meaning may be underestimated. 
The different colonization rates between dogs and cats of the two staphylococci species can 
indicate that the relative risk of MRSA and MRSP colonization might vary between the two 
host species, with MRSP being more frequent among dogs and MRSA among cats. The high 
rate of colonization of MRSP by dogs is likely to be due to host specificity, given that S. 
pseudintermedius is the pathogen more frequently isolated from dogs (Sasaki et al., 2010). 
However, the same is not true for cats and the higher rate of MRSA colonization is not fully 
understood. Weese and van Duijkeren (2009) referred that MRSA colonization might be 
transient in dogs and cats perhaps because S. aureus is not naturally a predominant 
commensal in these species. With S. pseudintermedius being the most prevailing commensal 
at least in dogs the duration of colonization is probably longer. Yet further studies on the 
duration of colonization are needed to evaluate this. 
Routine decolonization therapy is not recommended in human or animals that have mucosae 
colonized with MRSA (Catry et al., 2010). Nevertheless decolonization with antimicrobial 
therapy may be measured in individual MRSA colonized animals as an option to control 
transmission of MRSA between animals or from animals to humans (Catry et al., 2010). 
Animal confinement may also be considered. Still no antimicrobial drugs for veterinary use 
have been effectively studied and approved for local or systemic application intended to 
resolve MRSA carrier status. For MRSP decolonization there are no recommendations for 





In conclusion, even though the frequency of MRSA colonization was low, carriage of MRSA 
by companion animals in the community is a serious public health problem and adequate 
measures are necessary to prevent MRSA from becoming endemic in the animal population. 
The frequency of isolation of MRSP in our study was high (6 %), considering that MRSP was 
first described in Europe in 2006 and in Portugal in 2007. This carriage rate suggests that 
these bacteria are quickly spreading through the canine population through all Europe, 
including Portugal. How this dissemination has occurred is not completely understood 
(Perreten et al., 2010; Ruscher et al., 2010), however colonization of healthy animals can be 
an important way of transferring the pathogen from animal to animal. 
Although isolation of MRSP is infrequent in humans, transmission of strains between animals 
and humans has occurred in the past (Weese and van Duijkeren, 2009; Chuang et al., 2010). 
More important, the MDRSP strains can serve as reservoirs of antimicrobial resistance genes 
that can, possibly, be transferred to other bacterial species like S. aureus, since the location of 
many of these resistance genes is on mobile elements. Subsequent clonal spread of such a new 
MRSA clone might be a threat for human health in the future. The same may be applied for 
virulent toxins encoding genes among MRSP CC71 strains, which can play an important role 
in the dissemination of this epidemic clone. Recommendations for treatment of MDRSP 
infections and decolonization are urgently needed and new treatments without the use of 
antimicrobials are required. More importantly, monitoring of MRSA and MRSP in 
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Table 1 – Species, gender, age and antimicrobial consumption of the companion animals 
colonized with MRSA and MRSP. 







FMV 1 Canine Female Unknown Surgery Spiramycin/Metronidazole Spiramycin/Metronidazole 






















Acid and Metronidazole 
Unknown 



















FMV 9 Canine Male 8 years Surgery 
Enrofloxacin, Cefoxitin and 
Metronidazole 
Unknown 



















Table 2 – Susceptibility testing by disk diffusion of 27 antimicrobial agents of methicillin-




Clinical Breakpoints Criteria 






































































 30 μg ≥ 17 15-16 - ≤ 14 S S S S S S S S S S S S 
Gentamicin
a
 10 μg ≥ 15 13-14 - ≤ 12 R R R R R R R R R S S S 
Kanamycin
a
 30 μg ≥ 18 14-17 - ≤ 13 R R R R R R R R R S S S 
Rifampicin
a
 5 μg ≥ 20 17-19 - ≤ 16 S S S S S S S S S S S S 
Cephalothin
a
 30 μg ≥ 18 15-17 - ≤ 14 S R R R R R R R R S S S 
Cefoxitin
b
 30 μg ≥ 20 - - ≤ 19 S R R R S R R S R S S S 
Oxacillin
a,c



















R R R 
Oxacillin
d,e









 10 U ≥ 29 - - ≤ 28 R R R R R R R R R R R R 
Ciprofloxacin
b
 5 μg ≥ 21 16-20 - ≤ 15 R R R R R R R R R R R R 
Enrofloxacin
a
 5 μg ≥ 23 - 17-22 ≤ 16 R R R R R R R R R R R R 
Levofloxacin
b
 5 μg ≥ 19 16-18 - ≤ 15 R R R R R R R R R R R R 
Marbofloxacin
a
 5 μg ≥ 20 15-19 - ≤ 14 R R R R R R R R R R R R 
Moxifloxacin
b
 5 μg ≥ 24 21-23 - ≤ 20 R R R R R R R R R R R R 
Norfloxacin
b
 10 μg ≥ 17 13-16 - ≤ 12 R R R R R R R R R R R R 
Ofloxacin
b
 5 μg ≥ 18 15-17 - ≤ 14 R R R R R R R R R R R R 
Vancomycin
a
 30 μg ≥ 15 - - - S S S S S S S S S S S S 
Clindamycin
a
 2 μg ≥ 21 15-20 - ≤ 14 I R R R R R R R R S S S 
Erythromycin
a
 15 μg ≥ 23 14-22 - ≤ 13 R R R R R R R R R S S S 
Linezolid
b
 30 μg ≥ 21 - - - S S S S S S S S S S S S 
Chloramphenicol
a





15 μg ≥ 19 16-18 - ≤ 15 S S S S S S S S S S S S 
Tetracycline
a
 30 μg ≥ 19 15-18 - ≤ 14 S R R R R R R R R S S S 
Trimethoprim
b
 5 μg ≥ 16 11-15 - ≤ 10 R R R R R R R R R S S S 
Nitrofurantoin
b
 300 μg ≥ 17 15-16 - ≤ 14 S S S S S S S S S S S S 
Fusidic Acid
f
 10 μg ≥ 21 20 - ≤ 19 S S S S S S S S S S S S 
Mupirocin
g
 5 μg ≥ 14 - - ≤ 13 S S S S S S S S S S S S 
Abbreviations: NA, not applicable; R, resistant; S, susceptible. 
Inhibition zone diameters were interpreted according to: 
(a)




CLSI M100-S17 (M2) 
(c) 
Bemis et al., 2009 
(d) 
Criteria only for MRSA 
(e) 
Criteria only for MRSP 
(f)
 Toma and Barriault 1995 
(g)
 Fuchs et al., 1990 
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Table 3 - Origin, genotypic characteristics and antimicrobial resistant patterns of mecA-positive S. aureus and S. pseudintermedius strains isolated. 





Tandem Repeat Sequence  CC 
PFGE 
Subtype 






















 V t06 r01r02 r03 r03 r06 r05 68 A 





























III t02 r01r02 r03 r03 r03 r06 r05 71 B1 





























III t02 r01r02 r03 r03 r03 r06 r05 71 B2 





























III t02 r01r02 r03 r03 r03 r06 r05 71 B1 





























III t02 r01r02 r03 r03 r03 r06 r05 71 B1 





























III t02 r01r02 r03 r03 r03 r06 r05 71 B3 





























III t02 r01r02 r03 r03 r03 r06 r05 71 B1 





























III t02 r01r02 r03 r03 r03 r06 r05 71 B1 














































 IV t032 



















 IV t032 



















 IV t032 
r26 r23 r23 r13 r23 r31 r29 r17 r31 r29 r17 r25 r17 r25 
r16 r28 
22 C 
Abbreviations: Cn, gentamicin; K, kanamycin; Cip, ciprofloxacin; Enr, enrofloxacin; Lev, levofloxacin; Mar, marbofloxacin; Mxf, moxifloxacin; Nor, norfloxacin; Ofx, 




Annex X – Inquiry considering characteristics of the sampled animals 
Nome do Animal 
[Animal Name] 





Nome do Dono 
[Owner Name] 






Sexo do Animal 
[Gender] 













[No]     
Vive com outros animais? 























      
              
Fez no último ano algum 
antibiótico? 








      
Fez no último mês algum 
antibiótico? 








      
Já realizou alguma cirurgia? 







      
Última vez que esteve no 
Médico Veterinário? 
[Last visit to the Veterinary] 









      
Já esteve em algum canil? 












       
Motivo do Internamento 
[Motive for admission] 
            
              
       
 
